col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


614 Results       Page 1

 [1] 
The American Association of Immunologists: The Journal of Immunology
  original article Date Title Authors   All Authors
1 [GO] 2026―Apr―27 Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19 Sarah Benezech, Louis Picq, Marine Villard, Noémi Rousseaux, Ameline Hamond, Omran Allatif, et al. (+5)
2 [GO] 2026―Mar―18 CXCL13/CXCR5 chemokine axis promotes antiviral CXCR5+CD19+ B Cells and follicular/effector CXCR5+CD4+ T Cells in the lungs associated with protection from severe and fatal COVID-19 following infection with pathogenic SARS-CoV-2 Delta variant Hawa Vahed, Aziz A Chentoufi, Swayam Prakash, Afshana Quadiri, Sweta Karan, Yassir Lekbach, et al. (+8)
3 [GO] 2026―Mar―01 Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters Nadia Soudani, John Sidney, Ricardo Da Silva Antunes, James Brett Case, Ruby Sharma, Isabella Brew, et al. (+5)
4 [GO] 2025―Nov―21 Exploring signatures of inflammation in long COVID using a scaffolded approach to teaching with primary literature 3328 Rachel E. Penton, Madison Meuler, Kaitlyn Casimo
5 [GO] 2025―Nov―21 Treg cell epigenetic modifications controlling Brain fog in Long COVID 9015 Hani Harb
6 [GO] 2025―Nov―21 Leveraging virus-specific T cells as antigen biosensors to interrogate the pathogenesis of long COVID 3632 Mark M. Painter, David B. Reeg, Naomi R. Douek, Josephine R. Giles, Michael J. Peluso, Timothy J. Henrich, et al. (+3)
7 [GO] 2025―Nov―21 A causal link between autoantibodies and neurological symptoms in long COVID 2133 Keyla Sa, Julio Silva, Rafael Bayarri-Olmos, Ryan Brinda, Robert Alec, Rath Constable, et al. (+15)
8 [GO] 2025―Nov―21 Impact of SARS-CoV2 infection on the neuropathogenic potential of myelin-primed Th17 cells in an animal model of MS 2436 Baweleta Isho, Catherine Chi, Salma Sheikh-Mohamed, Jennifer L Gommerman
9 [GO] 2025―Nov―21 Caspase-4/11 induces lung inflammation and dampens the humoral immune response in SARS-CoV2 infected mice 3644 Mohamed Medhat Samir Ibrahim Ahmed Shamseldin, Mostafa Eltobgy, Heba Amer, Owen Witham, Jihad Omran, Rabab Abdelaleem, Amal Omar Amer
10 [GO] 2025―Nov―21 The Ad5/35 Platform-Based Vaccines for SARS-CoV-2: A Strategy to Counter Evolving Variants 2324 Chang-Yuil Kang, Soojeong Chang, Jieun Shin, Seowoo Park, Hyemin Park, Jong Heon Kim, et al. (+5)
11 [GO] 2025―Nov―21 SARS-CoV-2-specific antibody responses in Filipinos residing in Hawaii 3786 Jourdan Kamakanamakamae Posner McMillan, Yurim Hong, Sandra Perreira Chang
12 [GO] 2025―Nov―21 VirTac, a modular lentiviral-based platform, elicits selective and marked expansion of HIV-, CMV- and SARS-CoV-2-specific T cell responses, validating its applications for adoptive T cell therapies 2374 Marta Santos Bravo, Erin Cole, April Mueller, Christopher Hiner, Agnes Syndenstricker, Adilyn Voss, et al. (+4)
13 [GO] 2025―Nov―21 TLR4 and Myd88/TRIF signaling serve as novel immune sensor and adapters of SARS-CoV-2-membrane (M) protein induced immune response 2730 Paige Marie Johnson, Rakshya Shrestha, Cody Whitley, Rudra Channappanavar
14 [GO] 2025―Nov―21 Novel role of TLR-ERK1/2 activation in SARS-CoV-2-induced dysregulated immunity 3869 Rakshya Shrestha, Roshan Ghimire, Cody Whitley, Paige Marie Johnson, Rudra Channappanavar
15 [GO] 2025―Nov―21 Pathogenesis and microbiome characterization of SARS-CoV-2 variants in K18-hACE2 transgenic mice 9174 Keun Bon Ku, Chae Won Kim, Insu Hwang, Hi Eun Jung, Kyun Do Kim, Heung Kyu Lee
16 [GO] 2025―Nov―21 Novel use of a bead-based immunoassay to quantify SARS-CoV-2 variant-specific antibody avidity 4661 Dylan George, M. Jana Broadhurst
17 [GO] 2025―Nov―21 SARS-CoV-2 variants exhibit differential gut tropism and dysbiosis in Syrian golden hamsters 2098 Santhosh Kambaiah Nagaraj, Christy Margrat Joy, Rohan Narayan, Rishad Shiraz, Sumandeep Kaur, Oyahida Khatun, et al. (+2)
18 [GO] 2025―Nov―21 Lipid nanoparticle SARS-CoV-2 vaccine-mediated immunopeptidome identification 4042 Julie M. Rumble, Seeta Nyayapathy, J Paige Gronevelt, Richard Jones
19 [GO] 2025―Nov―21 Altered SARS-CoV-2 Vaccine Responses in People Living with HIV: Roles of ART, HIV-Specific T-Cells, and CD4 Deficiency 9309 Sean Michael Litwin, Ivy V. Trinh, Shuagnyi Bai, Gilberto Sabinos-Santos, Sherry Tong, Amelie E. Murrell, et al. (+15)
20 [GO] 2025―Nov―21 Comparing the diagnostic specificity of flow cytometry-based probe staining and ELISPOT for detection of SARS-CoV-2 Spike-reactive memory B cells using defined cohorts of cryopreserved human PBMC 9313 Greg A. Kirchenbaum, Georgia Stylianou, Sharon Cookson, Paul V. Lehmann, Stephen M. Todryk
21 [GO] 2025―Nov―21 Virus like particle (VLP)-based delivery of SARS-CoV-2 spike RBD-GM-CSF fusion protein induces durable and protective response 2548 Ramireddy Bommireddy, Shannon Stone, Amany Elsharkawy, Kristen M. Jacobsen, Christopher D. Pack, Sampath Ramachandiran, et al. (+3)
22 [GO] 2025―Nov―21 Impact of Single Point Mutations in the SARS-CoV-2 Spike Protein RBD on B-Cell Receptor Diversity and Cross-Reactivity 4525 Peace O. Olatoyinbo, Karen Paco, Animesh Ray, Jennifer Hernandez, Zihao Zhang, Sanaz Zebardast, et al. (+12)
23 [GO] 2025―Nov―21 Increased antibody diversification in mice vaccinated with a self-amplifying RNA versus mRNA directed against SARS-CoV-2 spike protein 9225 Jennefer A. Par-Young, Lais Osmani, Edward H. Doherty, Marta Piecychna, Suraj Abraham, Nikita Jain, et al. (+7)
24 [GO] 2025―Nov―21 Enhanced antibody class switching and T cell responses to a self-amplifying RNA vs mRNA vaccine against SARS-CoV-2 spike protein 4547 Edward H. Doherty, Jennefer Par-Young, Lais Osmani, Renata Filler, Marta Piecychna, Suraj Abraham, et al. (+10)
25 [GO] 2025―Nov―21 SARS-CoV-2 spike epitopes as a novel clinically-relevant biomarker for post-COVID syndrome 3558 Clara Luzia Magnus, Annika Walter, Lars Klaphecke, Sandra Schaubschläger, Tabea Gerschütz, Annelie Plentz, et al. (+27)
26 [GO] 2025―Nov―21 Vascular dysfunction and cytokine release syndrome: influence of inflammatory cytokines on barrier resistance of human aortic endothelial cell monolayers treated with SARS-CoV-2 proteins 9113 Carmen Elaine Campbell, William A. Boisvert
27 [GO] 2025―Nov―21 Dynamic evolutionary forces shaping the SARS-Cov-2 receptor binding domain 2874 Sanaz Zebardast
28 [GO] 2025―Nov―21 Sequencing analysis of B cell receptor repertoire in a BNT162b2 vaccinee after SARS-CoV-2 Omicron BA5 breakthrough infection: a case study 4586 Bohao Chen, Mengxiao Luo, Zhiwei Chen
29 [GO] 2025―Nov―21 Highly conserved conformational “Jing” epitopes overcome SARS-CoV-2 Omicron antigenic drift and shift 3411 Zhiwei Chen, Mengxiao Luo, Runhong Zhou
30 [GO] 2025―Nov―21 Host protein synthesis shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 3153 Chun-Chieh Hsu, Maudry Laurent-Rolle, Joanna Barbara Pawlak, Peter Cresswell
31 [GO] 2025―Nov―21 Altered germinal center outputs to SARS-CoV-2 mRNA vaccination in inflammatory bowel disease patients treated with anti-TNF biologics 2707 Michelle W Cheung, Samantha Xu, Janna Shapiro, Roaya Dayam, Freda Qi, Melanie Delgado-Brand, et al. (+9)
32 [GO] 2025―Nov―21 SARS-CoV-2 mRNA vaccination elicits distinct pharyngeal mucosal B cell responses in children compared to infection 3915 Qin Xu, Pamela Mudd, Lela Kardava, Hengameh Behzadpour, Lorenza Bellusci, Gabrielle Grubbs, et al. (+11)
33 [GO] 2025―Nov―21 Drivers of differential antibody breadth in SARS-CoV-2 mRNA vaccination and infection 4823 Oliver Fabian Wirz, Prasanti Kotagiri, Emily Haraguchi, Katharina Röltgen, Molly Hunter, Erin Craig, et al. (+28)
34 [GO] 2025―Nov―21 Caspase11 modulates the adaptive immune response in SARS-CoV-2 infection through innate immune regulation 4503 Mostafa Eltobgy, Benjamin Segal, Eugene M. Oltz, Jacob Yount, Shahid Nimjee, Purnima Dubey, Amal Amer
35 [GO] 2025―Nov―21 Macrophage peroxisomes guide alveolar regeneration and limit post-acute sequelae of SARS-CoV-2 infection (PASC) 2101 Xiaoqin Wei, Jie Sun
36 [GO] 2025―Nov―21 Resistance and susceptibility markers of SARS-CoV-2 infection in neutrophils response from discordant couples 4014 Luciane Alarcão Dias-Melicio, Thayná Ruiz Ferreira, Ana Laura Ortega Dezen, Fernando Couso Correa, Larissa Ragozo Cardoso de Oliveira, Camila Lopes Simeoni, et al. (+2)
37 [GO] 2025―Nov―21 Roles of CCR10-regulated mucosal IgA responses in lung SARS-CoV-2 infection clearance and pathogenesis 3261 Juan Garcia, Na Xiong
38 [GO] 2025―Nov―21 Pre-pandemic cross-reactive T-cell responses are associated with subsequent protection against SARS-CoV-2 infection, but not against symptomatic illness 2345 Su Yang, Suji Uduyakumar, Cong Xie, Sanja Huibner, Karen Colwill, Anne-Claude Gingras, et al. (+2)
39 [GO] 2025―Nov―21 Identification and functional role of medulla germinal centers during SARS-CoV-2 infection and reinfection in a macaque model using Xenium in situ spatial transcriptomics 9127 Young Min Woo
40 [GO] 2025―Nov―21 CXCR3+ Alveolar macrophages help to clear viral load during SARS-CoV-2 infection 9049 Md Jashim Uddin
41 [GO] 2025―Nov―21 Investigating functional NETosis pathways and siRNA mediated suppression of NETosis in feline and HL-60 neutrophil in vitro models of SARS-CoV-2 infection 2738 Sachithra J. Gunasekara, Shoroq Shatnawi, Jennifer Rudd
42 [GO] 2025―Nov―21 Intranasal co-delivery of measles virus and mumps virus expressing nucleocapsid and prefusion spike proteins enhances protection against SARS-CoV-2 infection 2659 Michelle Chamblee, Cheng Chih Hsu, Yuexiu Zhang, Sungjun Yoo, Chengjin Ye, Yajie Liu, et al. (+12)
43 [GO] 2025―Nov―21 Obesity Alters the Metabolic and Immunologic Response of Pulmonary T Cells to SARS-CoV-2 Infection 2143 Shailendra Kumar Verma, Julia Timis, Erin Maule, Annie Elong Ngono, Fernanda Ana-Sosa-Batiz, Robyn Miller, et al. (+5)
44 [GO] 2025―Nov―21 Immunogenicity of Synthetic MVA-based Vaccine COH04S1 Against SARS-CoV-2 in Post-HCT/CAR-T Patients and Its Cross-Protective Potential Against Mpox 9352 Sandra Ortega-Francisco, Sandra Ortega-Francisco, Flavia Chiuppesi, Miguel-Angel Gutierrez, Jing Li, Jada Mack-Onyeike, et al. (+15)
45 [GO] 2025―Nov―21 Alterations of B cell responses to SARS-CoV-2 in Long COVID 2566 Michela Locci, Hannah Sharpe
46 [GO] 2025―Nov―21 HIF-dependent induction of alveolar miR-147b dampens SARS-CoV-2 immune evasion 3751 Xiaoyi Yuan, Jieun Kim, Katherine Figarella, Yanyu Wang, Oleg Makarevich, Wei Ruan, et al. (+18)
47 [GO] 2025―Nov―21 Single cell immune profiling of cryopreserved whole blood and reversibly fixed PBMCs from healthy donors reveals T cell expansions biasde towards putative SARS-CoV-2 epitopes 3259 Connor Kunihiro, Dagmar Walter, Yinzhou Zhu, Kelly Martin, Jawad Abousoud, Tingsheng Drennon, et al. (+5)
48 [GO] 2025―Nov―21 SARS-CoV-2 envelope protein induces alveolar hemorrhage and lupus nephritis in systemic lupus erythematosus via binding TLR2 to enhance cell death 9105 Yu-Tung Hsieh, Yi-Cheng Chen, Ching-Yen Tsai, Yu-Chi Chou, Chi-Fon Chang, Yi-Ting Yen, et al. (+4)
49 [GO] 2025―Nov―21 Cyclophilin-CD147 interaction facilitates SARS-CoV-2 entry and Toll-Like Receptor 7/8-mediated activation of human monocytes 9224 Hannes Stockinger
50 [GO] 2025―Nov―21 Vaccine-induced CD8 T-cells maintain enhanced cytotoxicity and proliferation in SARS-CoV-2 breakthrough infections in hematological cancer patients 4221 Darya Trubach, Konstantin Danilov, Ditte Stampe Hersby, Anne Ortved Gang, Susana Patricia Amaya Hernandez, Lasse Frank Voss, et al. (+3)
51 [GO] 2025―Nov―21 Uncovering the role of antigen-specific T cells in SARS-CoV-2 breakthrough infection 3518 Zhiheng Zhzha Zhao, Susana Patricia Amaya Hernandez, Darya Trubach, Lasse Frank Voss, Konstantin Danilov, Ditte Stampe Hersby, et al. (+4)
52 [GO] 2025―Nov―21 Novel Lineages of SARS-CoV-2 Receptor Binding Domain Monoclonal Antibodies Demonstrate Broad and Potent Neutralization Across SARS-CoV-2 and Other Sarbecoviruses 9206 Quenelle McKim, Lingshu Wang, Tongqing Zhou, Maryam Musayev, Sarah K. Smith, Chaim A. Schramm, et al. (+18)
53 [GO] 2025―Nov―21 Characterization of BST2-mediated restriction of SARS-CoV-2 and enhancement of Fc-mediated cellular responses 2097 Haley Aull, Ruth Serra-Moreno
54 [GO] 2025―Nov―21 Mechanisms of superior respiratory IgA responses against SARS-CoV-2 after mucosal vaccination 2158 Jinyi Tang, Arka Sen Chaudhuri, Panke Qu, Pei Li, Yajie Liu, Yue Wu, et al. (+25)
55 [GO] 2025―Nov―21 Cellular immune signatures associated with fast versus slow clearance of infectious SARS-CoV-2 4227 Lily Zemelko, Rafael Tibúrcio, Yen Y. Wang, Christian M. Constantz, Gina M. Borgo, Matthew H. Spitzer, et al. (+6)
56 [GO] 2025―Nov―21 Adjuvant-free intranasal T cell vaccine enhances protective mucosal immunity against SARS-CoV-2 3397 Genghao Chen, Steve Elledge, Anthony Griffiths, Rachel Olson, James J. Moon, Andrew D. Luster, et al. (+4)
57 [GO] 2025―Nov―21 Differential immune imprinting effects of seasonal common cold coronaviruses on breadth of responses to SARS-CoV-2 4766 David C. Brice, Chun-Yang Lin, Ashley H. Castellaw, Kaity Allen, Ericka K. Roubidoux, Scott A. Rown, et al. (+5)
58 [GO] 2025―Nov―21 Coronaviruses exacerbate pulmonary fibrosis via altered tryptophan metabolism and activation of non-canonical AHR signaling 3690 Hannah Carter, Bethany B. Moore, Stephen J. Gurczynski
59 [GO] 2025―Nov―21 Engineering recombinant ferret IgA against influenza viruses and coronaviruses for reagent validation and musocal immunity assessment 4743 Rose Miller, Justin Shepard, Stephen Mark Tompkins
60 [GO] 2025―Nov―21 Seasonal antibodies against beta human coronaviruses are associated with increased susceptibility to SARS-CoV-2 infection 3542 Hanna Oppenheimer, Shosh Zismanov, Lilach Friedman, Lior Nesher, Tomer Hertz
61 [GO] 2025―Nov―21 Critical role of myeloid cell TRAF6 signaling in coronavirus-induced antiviral and inflammatory responses 3866 Roshan Ghimire, Cody Whitley, Paige Marie Johnson, Rudra Channappanavar
62 [GO] 2025―Nov―21 Chimeric coronavirus spike combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent T helper cell and neutralising antibody responses in murine and non-human primate models 4642 Hyon-Xhi Tan, Veronica Zoest, Wen Shi Lee, Lydia Murdiyarso, Lauren Burmas, Anne Gibbon, et al. (+8)
63 [GO] 2025―Nov―21 Natural killer (NK) cell antibody-dependent cell-mediated cytotoxicity (ADCC) to the coronavirus OC-43 9107 Judith BCruz Amaya, Kabita Adhikari, Subhash Verma, Gulinare Halimu, Lai Wen, James Gern, Dorothy Hudig
64 [GO] 2025―Nov―21 Viral deISGylase activity antagonizes the host innate immune response and enhances coronavirus pathogenesis in a murine model of coronavirus infection 4265 Mudassir Ali, Amornrat O’Brien, Fernando Moreira, Lucky Sarkar, Michaela Gack, Susan Baker
65 [GO] 2025―Nov―21 The autoimmunity-associated minor allele of PTPN22 enhances innate antiviral immunity during coronavirus infection 3695 Alec Bevis, Catherine Kerr, Kate Rosa, Tammy Cockerham, Nancy Schwarting, Anthony R. Fehr, Robin C. Orozco
66 [GO] 2025―Nov―21 Enhancing lung immunity against COVID-19: the role of ATP in TRM cell generation 9389 Marcos Vinicios Pinheiro Cione, Igor Santiago-Carvalho, Luciana dos Santos Barros Manhaes, Rodrigo Jose Rocha Xavier Freitas, Rogerio Silva do Nascimento, Viviane Fongaro Botosso, et al. (+4)
67 [GO] 2025―Nov―21 Lipid nanoparticles carrying neutrophil extracellular trap inhibitors specifically target lung neutrophils and prevent COVID-19-associated lung injury in mice 9303 Juwon Park, Haeun Shin, Stefanos Giannakopoulos, Joo Dong Park, Chun Gwon Park, Wooram Park, Saguna Verma
68 [GO] 2025―Nov―21 Fighting Covid-19 with NLRX1 9340 Mackenzie K. Woolls, Hannah Ivester, Julia Gregory, Irving Coy Allen
69 [GO] 2025―Nov―21 Co-administration of DTaP and mRNA COVID-19 vaccines results in altered immune profile and enhanced protection against aerosol challenge of B. pertussis in mice 3042 Nathaniel A. Rader, Dylan T. Boehm, Josh Chapman, Melissa Cooper, Casey Cunningham, Carleena Marie, et al. (+8)
70 [GO] 2025―Nov―21 Pregnancy reduces COVID-19 vaccine immunity against novel variants of concern 4377 Maclaine Parish, Lizeth Gutierrez, Jaiprasath Sachithanadham, Han-Sol Park, Anna Yin, Laura St Clair, et al. (+7)
71 [GO] 2025―Nov―21 Suboptimal Fc-mediated antibody responses in people with vs. without HIV after COVID-19 vaccinations 2174 Jeromine Klingler, Juan C Bandres, Ismael Pena, Katherine Bolanos Roldan, Brian Monahan, Yuexing Chen, et al. (+3)
72 [GO] 2025―Nov―21 Long-term consequence of SARS-CoV-2 on monocyte phenotype in COVID-19 survivors 3120 Thomas Ken Awamura, Stefanos Giannakopoulos, Natalie Subia, Vedbar Khadka, Domic Chow, Cecilia M. Shikuma, et al. (+2)
73 [GO] 2025―Nov―21 Comprehensive longitudinal profiling of SARS-CoV-2 antigens reveals COVID-19 severity-associated CD8+ T-cell activation and functional impairment 3496 Susana Patricia Amaya Hernandez, Kamilla Kjærgaard Munk, Konstantin Danilov, Mohammad Kadivar, Ditte Stampe Hersby, Tripti Tamhane, et al. (+4)
74 [GO] 2025―Nov―21 Comprehensive profiling of COVID-19 severity using NULISAseq: Predictive insights and immune dynamics from the IMPACC study 2209 Koji Abe, Tyson H Holmes, Tran T Nguyen, Holden T Maecker
75 [GO] 2025―Nov―21 Identifying one-carbon metabolism as a predictor of COVID-19 severity in the IMPACC cohort 3975 Caitlin Syphurs, Boryana Petrova, Joann Diray-Arce, Andrew Culhane, Jing Chen, Ernie Chen, et al. (+8)
76 [GO] 2025―Nov―21 12-Lipoxygenase Drives Hyperinflammatory Responses and Enhances COVID-19 Severity 9032 Chandra Shekhar Bakshi, Melinee D’silva, Jerry L. Nadler, Dave Meloney
77 [GO] 2025―Nov―21 Antibody signatures of COVID-19 protection 3824 Teresa A. Aydillo Gomez, Amaya Rojo, Sadaf Aslam, Fahmida Alam, Alba Escalera, Vicente Villamandos, et al. (+5)
78 [GO] 2025―Nov―21 Unique extrafollicular B cell expansion in COVID-19 patients who developed prothrombotic platelet-activating antibodies 2427 Nathan Witman, Mei Yu, Lu Zhou, Weiguo Cui, Richard Aster, Mary Beth Graham, et al. (+2)
79 [GO] 2025―Nov―21 Lipidomic analysis reveals novel biomarkers in plasma extracellular vesicles from COVID-19 patients 9415 Niharika Bala, Nancy D. Denslow, Sarah C. Glover, Abdel A. Alli
80 [GO] 2025―Nov―21 How to make friends and increase vaccinations - lessons learned from the COVID-19 pandemic in the Dutch Caribbean 3698 Keri Csencsits-Smith, Rachel Robson
81 [GO] 2025―Nov―21 Population-matched IGHV antibody haplotypes and their role in COVID-19 outcomes 4236 Michelle Grill, John Berestecky, Brien K. Haun
82 [GO] 2025―Nov―21 SARS-CoV-2 infection versus COVID-19 mRNA vaccination-induced Spike-specific memory B cells: frequencies, Ig class and subclass usage, cross-reactivities, and affinity distributions 9044 Greg A. Kirchenbaum, Lingling Yao, Noemi Becza, Paul V. Lehmann
83 [GO] 2025―Nov―21 Impact of COVID-19 mRNA vaccination on metabolic profiles in patients with lymphoid malignancies 3780 Joann Diray-Arce, Meagan Karoly, Jing Chen, Alexandra Tong, Hannah Levine, Zoe Swank, et al. (+6)
84 [GO] 2025―Nov―21 The mechanism for maintenance of memory CD8 T Cells after COVID-19 mRNA vaccination 9160 Takuto Nogimori, Yoshinori Okina, Yuji Masuta, Victor Appay, Takuya Yamamoto
85 [GO] 2025―Nov―21 Lung Microbiota Dynamics during Mild COVID-19 Infection in Non-Human Primate 9129 Yujin Kim, Seonghan Jang, Choong-Min Ryu, Jung Joo Hong
86 [GO] 2025―Nov―21 Transient nasal anti-interferon autoantibodies predict better outcomes in COVID-19 infection 4226 Benjamin R. Babcock, Astrid Kosters, Devon James Eddins, Maria Sophia, Baluyot Donaire, Sannidhi Sarvadhavabhatla, et al. (+15)
87 [GO] 2025―Nov―21 Distinct metabolomic profiles and systemic lipid dysregulation in longitudinal analysis of COVID-19 disease trajectory and long COVID outcomes 2785 Jing Chen, Kevin Mendez, Boryana Petrova, Annmarie Hoch, Sanya Thomas, Meagan Karoly, et al. (+14)
88 [GO] 2025―Nov―21 Lymphocytic infiltration in the lungs of fatal cases of COVID-19 coincides with cessation of viral replication 4444 Andrew Platt, Paul Mallory, Sabrina C. Ramelli, Ashley Cardamone, Christine Newkirk, Sydney R. Stein, et al. (+9)
89 [GO] 2025―Nov―21 Immunological and molecular drivers of severe cases in the SARS-CoV-2 Delta wave revealed through genomic analysis of a COVID-19 cohort 2863 Gourav Bhayana, Rishad Shiraz, Kambaiah Santhosh Nagaraj, Rohan Narayan, Shashank Tripathi
90 [GO] 2025―Nov―21 Dysregulated regulatory T cell response in immunosuppressed individuals is associated with increased inflammation in COVID-19 breakthrough infections 2587 Leslie Chan, Kassandra Pinedo, Mikayla Stabile, Rebecca Hamlin, Shaun Pienkos, Samuel Yang, et al. (+7)
91 [GO] 2025―Nov―21 T cell responses to COVID-19 bivalent booster vaccine 2422 Amparo Martinez-Perez, Rosa Isela Galvez, Alba Grifoni, Alessandro Sette, Peter K Gregersen, Daniela Weiskopf
92 [GO] 2025―Nov―21 Glucagon-like peptide-1 receptor agonist prevents pulmonary post-acute sequelae of COVID-19 associated with type 2 diabetes 3430 Runhong Zhou, Qing Shen, Zhiwei Chen
93 [GO] 2025―Nov―21 Single-cell analysis of platelet heterogeneity in COVID-19 and sepsis using foundation models 2811 Xinru Qiu
94 [GO] 2025―Nov―21 Th2 immune responses promote anti-viral and anti-inflammatory activity during mild COVID-19 9405 Rafael A. Medina, Tamara García-Salum, Slim Fourati, Gonzalo Valenzuela, Catalina Pardo-Roa, Eileen Serrano, et al. (+14)
95 [GO] 2025―Nov―21 Immunopathogenesis and Vaccine Development: From Dengue to COVID-19 9216 Chwan-Chuen King, Chin-Rur Yang, Tzong-Shiann Ho
96 [GO] 2025―Nov―21 Immunogenicity and Durability of Antibody Responses to homologous and heterologous Vaccination with BNT162b2 and ChAdOx1 Vaccines for COVID-19 4665 Dong in Kim
97 [GO] 2025―Nov―21 Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19 2886 James Badger Wing, David Priest, Takeshi Ebihara, Janyerkye Tulyeu, Jonas Søndergaard, Hisatake Matsumoto
98 [GO] 2025―Nov―21 Unraveling the Dynamic Interplay of SARS-CoV-2 Neutralizing Monoclonal Antibodies and Host Immunity in Hospitalized Patients with COVID-19 2264 Bei Wang, Jacquelynn Golubov, Patrick Poon, Qiaozhi Wei, Clarissa Lett, Fadi Shehadeh, et al. (+16)
99 [GO] 2025―Oct―08 Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity Anthonia E Osuagwu, Michael Payne, Jürgen Bosch, Uri Mbonye, Kien Nguyen, Jonathan Karn, et al. (+2)
100 [GO] 2025―May―23 Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts Joanne Byrne, Colette Marie Gaillard, Lili Gu, Alejandro Garcia-Leon, Orlaith Casey, Grace Kenny, et al. (+14)
101 [GO] 2025―May―01 Porcine respiratory coronavirus as a model for acute respiratory disease: mechanisms of different infection outcomes Ehsan Sedaghat-Rostami, Brigid Veronica Carr, Liu Yang, Sarah Keep, Fabian Z X Lean, Isabella Atkinson, et al. (+17)
102 [GO] 2025―Apr―16 Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination Chengchao Ding, Qianqian Chen, Yu Shi, Jiamin Liu, Lina Huang, Wei Wei, et al. (+5)
103 [GO] 2025―Apr―04 The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years Otto O Yang
104 [GO] 2025―Mar―09 Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2 Lauren Burmas, Wen Shi Lee, Andrew Kelly, Rosela Webster, Robyn Esterbauer, Stephen J Kent, et al. (+3)
105 [GO] 2025―Feb―24 Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies Miao Wang, Congcong Liu, Qing Fan, Yuehong Sun, Shilong Tang, Huimin Guo, et al. (+5)
106 [GO] 2025―Jan―23 Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2 Peiwen Qiao, Can Yue, Weiyu Peng, Kefang Liu, Shuting Huo, Di Zhang, et al. (+6)
107 [GO] 2024―Nov―08 High-throughput and high-dimensional single-cell analysis of antigen-specific CD4+ T cells in COVID-19 and influenza Yuwan Guo, Chao Huang, Ning Jiang
108 [GO] 2024―Nov―08 Electronic health record data shows immunosuppressive conditions are associated with poor outcomes in patients hospitalized for COVID-19 Vijeeth Guggilla, Jennifer Pacheco, Alexandre Carvalho, Anna Pawlowski, Grant Whitmer, Chad Achenbach, Theresa Walunas
109 [GO] 2024―Nov―08 A humanized ACE2 mouse model recapitulating age- and sex-dependent immunopathogenesis of COVID-19 Uni Park, Jae Hoon Lee, Uijin Kim, Yuri Kim, Kyeongseok Jeon, Ju-il Kang, et al. (+11)
110 [GO] 2024―Nov―08 Antibody profiling of COVID-19 patients reveals antibodies and autoantibodies that may be associated with faster recovery from COVID-19 Olusegun Onabajo, Petra Budde, Peter Kuebler, Manuel Bräutigam, Shivram Haridha, William Stubbings, et al. (+5)
111 [GO] 2024―Nov―08 Assessment of SARS-CoV-2 Spike and NCAP antigen-specific memory B cell frequency and Ig class/subclass usage following natural infection and/or COVID-19 mRNA vaccination Greg Kirchenbaum, Noemi Becza, Lingling Yao, Zhigang Liu, Jack Chepke, Paul Lehman
112 [GO] 2024―Nov―08 Next-generation B cell ImmunoSpot™ assays permit in-depth assessment of the B cell response elicited by SARS-CoV-2 infection and/or COVID-19 mRNA vaccination Greg Kirchenbaum, Paul Lehmann, Noemi Becza, Jack Chepke, Lingling Yao, Alexis Valente, Zhigang Liu
113 [GO] 2024―Nov―08 Compromised antibody responses and memory lymphocyte formation to COVID-19 mRNA vaccination in children with acute lymphoblastic leukemia undergoing maintenance chemotherapy Pei-De Chang, Chi-Chang Shieh
114 [GO] 2024―Nov―08 High sensitive detection and validation of neuronal specific autoantibodies in post COVID-19 patients with neurocognitive disorders Quanzhen Li, Junxia Wei, Luming Niu, Shuwei Yang, Chen Liang
115 [GO] 2024―Nov―08 Longitudinal characterization of CD8+ T cells recognizing a dominant epitope of SARS-CoV-2 spike protein in COVID-19 vaccinated and infected individuals Ainslee Zou, Jiangyuan Li, Joseph Chen, Mostafa Elbahnasawy, Cecily Choy, Jian Lu, et al. (+11)
116 [GO] 2024―Nov―08 Differential proteomic signatures of host responses following COVID-19 vaccination in individuals with or without prior SARS-CoV-2 infection Felipe Echeverri Tribin, Erin Williams, Juan Carreno, Florian Krammer, Michael Hoffer, Suresh Pallikkuth, Savita Pahwa
117 [GO] 2024―Nov―08 Abnormal uterine bleeding after COVID-19 vaccination in South Korea Dong Choon Park, Joon Hyung Yeo, Seung Geun Yeo
118 [GO] 2024―Nov―08 Coronavirus Immune History Affects Breadth of Anti-SARS-CoV-2 Receptor-Binding Domain Responses. David Brice, Chun-Yang Lin, Ashley Castellaw, E Allen, Marie Wehenkel, Carlessia Lewis, et al. (+6)
119 [GO] 2024―Nov―08 The Autoimmunity-Associated Minor Allele of PTPN22 Enhances Antiviral Immunity During Coronavirus Infection Alec Bevis, Anam Shaikh, Catherine Kerr, Jenna Barnes, Kate Rosa, Tammy Cockerham, et al. (+3)
120 [GO] 2024―Nov―08 TLR7-agonist nanoparticle adjuvant modulates germinal center responses and promotes broad antibody responses against heterologous viral strains of influenza and SARS-CoV-2 Qian Yin, Wei Luo, Bali Pulendran, Mark Davis
121 [GO] 2024―Nov―08 THE ONES AND TWOS: PATTERN RECOGNITION RECEPTOR NLRX1 IMPACTS VIRAL REPLICATION OF AND IMMUNE RESPONSE TO SARS-COV-2 Hannah Ivester, Mackenzie Woolls, Madeline Mott, Julia Gregory, Holly Morrison, Juselyn Tupik, et al. (+4)
122 [GO] 2024―Nov―08 SARS-CoV-2 adaptive responses in Confirmed Positive (CP) and non-infected household contacts (HC) Yeji Lee, Benjamin Goodwin, Alison Tarke, April Frazier, Alba Grifoni, Jennifer Dan, et al. (+2)
123 [GO] 2024―Nov―08 Respiratory mucosal immunity against SARS-CoV-2 after vaccination and infection Jinyi Tang, Arka Chaudhuri, Panke Qu, Yue Wu, Kristin Wavell, Marthajoy Spano, et al. (+4)
124 [GO] 2024―Nov―08 The breadth and neutralizing activity of SARS-CoV-2 antibodies among children 6 months to 4 years of age following vaccination with mRNA-1273 or BNT162b2 Caitlin Williams, Trisha Dalapat, Elena Giorgi, Jillian Hurst, Savannah Herbek, Jui-Lin Chen, et al. (+10)
125 [GO] 2024―Nov―08 SARS-Cov-2 antigen exposure history shapes post-infection antibody epitope and immune pressure distribution Ayijiang Yisimayi, Fanchong Jian, Jing Wang, Weiliang Song, Yunlong Cao
126 [GO] 2024―Nov―08 Deciphering TCR-pMHC Interactions in Human Memory T Cells: Biophysical Insights into SARS-CoV-2 Antigen Recognition Xiangcheng Chen
127 [GO] 2024―Nov―08 Lipid nanoparticle encapsulation enhances the immunogenicty of a SARS-CoV-2 Delta variant-based DNA vaccine and enables protection against heterologous omicron subvariants Levi Tamming, Diana Duque, Casey Lansdell, Sathya Raman, Lisheng Wang, Anh Tran, et al. (+2)
128 [GO] 2024―Nov―08 Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice Jianping Li, Kevin Hsu, Tanya Hoang, ZHENG XIA, YONGJUN SUI, Jay Berzofsky
129 [GO] 2024―Nov―08 Longitudinal assessment of humoral immune response against SARS-CoV-2 in solid cancer patients: Implications for vaccination strategies Ji Eun Oh, Eunjin Lee, Ki Seong Lee
130 [GO] 2024―Nov―08 Human Immune repertoire and gene expression in pediatric and adult SARS-CoV-2 infected patients using single cell multi-omics approaches xuhuai ji, Lael Yonker, Molly Miranda, Thomas Bernard Kinane, Matthew Chang, Sundari Suresh, et al. (+3)
131 [GO] 2024―Nov―08 Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis Ji Hyun Choi, Gi Uk Jeong, Insu Hwang, Wooseong Lee, Gun Young Yoon, Hae Soo Kim, et al. (+6)
132 [GO] 2024―Nov―08 Excess airway iron during severe SARS-CoV-2 infection impairs neutrophil antifungal activity enabling 2° mold infection Sawanan Saitornuang, Cuong Lam, Ashleigh Riegler, Will Meehan, Joo-Yeun Oh, Rakesh Patel, et al. (+4)
133 [GO] 2024―Nov―08 Understanding variant-specific variations in neutrophil functional kinetics associated with SARS-CoV-2 infection in a feline animal model Sachithra Gunasekara, Shoroq Shatnawi, Breya Ludwig, Sunil More, Craig Miller, Jennifer Rudd
134 [GO] 2024―Nov―08 FOXO1 inhibitor has the antiviral and anti-inflammatory effects against SARS-CoV-2 infection in in vitro and in vivo models. Ryutaro Furukawa, Atsushi Hara, Noriko Ouji-Sageshima, Masahiro Kitabatake, Shigeyuki Shichino, Satoshi Ueha, et al. (+2)
135 [GO] 2024―Nov―08 Exploring the spatiotemporal cellular dynamics of draining lymph nodes during primary and secondary SARS-CoV-2 infection recovery Taehwan Oh, YoungMin Woo, Green Kim, Seung Ho Baek, Bon-Sang Koo, Eun-Ha Hwang, et al. (+4)
136 [GO] 2024―Nov―08 Intestinal helminth infection impairs vaccine-induced T cell responses and protection against a SARS-CoV-2 Omicron variant in mice Pritesh Desai, Courtney Karl, Baoling Ying, Chieh-Yu Liang, Tamara Garcia-Salum, Ana Carolina Santana, et al. (+6)
137 [GO] 2024―Nov―08 Increased interleukin-6 correlates with LAMP1 expression in NK cells and hospital stay of patients with SARS-COV-2 pneumonia. KENIA OSUNA ESPINOZA, Manuel Mejía Torres, Adrian Camacho Ortiz, Eduardo Perez Alba, Mario Salinas Carmona, Adrian Rosas Taraco
138 [GO] 2024―Nov―08 Glucocorticoid-mediated immunosuppression prolongs SARS-CoV-2 replication in the lower airways of rhesus macaques Christine Nelson, Keith Kauffman, Shunsuke Sakai, Felipe Gomez, Laura Via, Daniel Barber
139 [GO] 2024―Nov―08 Comparing the immunogenicity of different SARS-CoV-2 spike vaccine platforms in mice Min Han Lew, Sarah Sanchez, Pablo Penaloza-Macmaster
140 [GO] 2024―Nov―08 Recall of cross-reactive memory B cells enhances antibody durability and breadth against SARS-CoV-2 variants Yuezhou Chen, Youyi Wang, Yuanhao Hu, Nuo Gong, Yunfeng Li, Jiayi Huang, et al. (+2)
141 [GO] 2024―Nov―08 SARS-CoV-2 WA1 induces distinct immune transcriptome profiles in human and deer primary respiratory epithelial cells Rahul Nelli, Kaitlyn Sarlo Davila, Kruttika Phadke, Rachel Ruden, Bryan Bellaire, Yongming Sang, et al. (+2)
142 [GO] 2024―Nov―08 The gastrointestinal tract-restricted helminth H. polygyrus bakeri protects against SARS-CoV-2-induced lung disease in mice Courtney Karl, Pritesh Desai, Meizi Liu, Samantha Mackin, Zhenlu Chong, Jinsheng Yu, et al. (+2)
143 [GO] 2024―Nov―08 Harnessing a potent combination to address a pandemic virus: SARS-CoV-2-specific antiviral and anti-inflammatory activity of BromAc Jordana Coelho-dos-Reis, Geovane Marques Ferreira, Erik Reis, Felipe Clarindo, Ágata Lopes-Ribeiro, Letícia Gomes-de-Pontes, et al. (+8)
144 [GO] 2024―Nov―08 Exploring Pre-Pandemic SARS-CoV-2-Specific B Cell Responses in the West African Population. Pragati Sharma, Jonathan Hurtado, Terrence Messmer, Bryan Briney
145 [GO] 2024―Nov―08 The immunological aftermath of SARS-CoV-2: How prior infection impacts subsequent pulmonary injury Lydia Roberts, Tara Wehrly, Benjamin Schwarz, Eric Bohrnsen, Carl Shaia, Catharine Bosio
146 [GO] 2024―Nov―08 Elucidating the role of macrophage galactose-type lectin 1 (MGL-1) in the pathogenesis and resolution of SARS-CoV2 Jaid Perez, Lucinda Puebla-Clark, Matt Huante, Maria Orozco, Kubra Naqvi, Yazmin Martinez-Martinez, et al. (+4)
147 [GO] 2024―Nov―08 Investigating biomarkers and therapeutic approaches in mouse models of SARS-CoV2 induced Long COVID with neuroinflammation and cognitive deficits. Peiwen Lu, Anthony Fernández-Castañeda, Anna C Geraghty, Eric Song, Michelle Monje, Akiko Iwasaki
148 [GO] 2024―Nov―08 Plasmacytoid dendritic cells are central regulators of the humoral ChAdOx1 nCoV-19 vaccine response in a human tonsil organoid model Nicholas Provine, Maria Pudjohartono, Kate Powell, Helen Ferry, Ellie Barnes, Paul Klenerman
149 [GO] 2024―Nov―08 Single-cell proteomic analysis of peripheral blood mononuclear cells in patients with pulmonary long COVID Elizabeth Guinto, Grace Kuo, Melina Messing, Chung Cheung, Will Yip, Firoozeh Gerayeli, et al. (+3)
150 [GO] 2024―Nov―08 Oxidative stress is a shared characteristic of ME/CFS and Long COVID Vishnu Shankar, Julie Wilhelmy, Ellis Curtis, Basil Michael, Layla Cervantes, Vamsee Mallajosyula, et al. (+8)
151 [GO] 2024―Sep―11 Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG and IgA Antibody Profile at Delivery and 42 Days Postpartum Mirjam Druškovič, Miha Lučovnik, Vita Andreja Mesarič, Gorazd Kavšek, Marijana Vidmar Šimic, Andreja Trojner Bregar, et al. (+3)
152 [GO] 2024―Sep―09 Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection Kayla A. Holder, Danielle P. Ings, Kathleen E. Fifield, David A. Barnes, Keeley A. Barnable, Debbie O. A. Harnum, et al. (+2)
153 [GO] 2024―Jul―17 Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence Arman Izadi, Magdalena Godzwon, Anna Söderlund Strand, Tobias Schmidt, Susanna Kumlien Georén, Christian Drosten, et al. (+2)
154 [GO] 2024―Apr―29 A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera Patrick Budylowski, Serena L. L. Chau, Arinjay Banerjee, Furkan Guvenc, Reuben Samson, Queenie Hu, et al. (+19)
155 [GO] 2024―Apr―05 NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19 Madeline J. Lee, Izumi de los Rios Kobara, Trisha R. Barnard, Xariana Vales Torres, Nicole H. Tobin, Kathie G. Ferbas, et al. (+6)
156 [GO] 2024―Mar―27 Correction: Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan
157 [GO] 2024―Mar―22 The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease Suguru Saito, Najmeh Bozorgmehr, Wendy Sligl, Mohammed Osman, Shokrollah Elahi
158 [GO] 2024―Feb―12 Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency Lucy Kundura, Renaud Cezar, Emma Ballongue, Sonia André, Moïse Michel, Clément Mettling, et al. (+12)
159 [GO] 2024―Feb―09 Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort Koji Abe, Joanne C. Beer, Tran Nguyen, Ishara S. Ariyapala, Tyson H. Holmes, Wei Feng, et al. (+5)
160 [GO] 2024―Feb―05 Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report Pushpa Tandon, Natalie D. Abrams, Leela Rani Avula, Danielle M. Carrick, Preethi Chander, Rao L. Divi, et al. (+12)
161 [GO] 2024―Jan―12 Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells Anthony Maino, Axelle Amen, Joël Plumas, Lucie Bouquet, Marina Deschamps, Philippe Saas, et al. (+2)
162 [GO] 2024―Jan―10 Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection Christine M. Bradshaw, Teodora Georgieva, Trevor N. Tankersley, Tama Taylor-Doyle, Larry Johnson, Jennifer L. Uhrlaub, et al. (+2)
163 [GO] 2024―Jan―05 Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models Nisha Rajeswari Dhanushkodi, Swayam Prakash, Afshana Quadiri, Latifa Zayou, Ruchi Srivastava, Amin Mohammed Shaik, et al. (+10)
164 [GO] 2023―Dec―27 Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection Elvia E. Silva, Steven J. Moioffer, Mariah Hassert, Roger R. Berton, Matthew G. Smith, Stephanie van de Wall, et al. (+4)
165 [GO] 2023―Dec―20 Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies Tobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, Yu Gao, Andrea Ponzetta, Johanna Emgård, et al. (+17)
166 [GO] 2023―Nov―06 Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies John P. Evans, Shan-Lu Liu
167 [GO] 2023―Oct―02 Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species Mohammed Nooruzzaman, Diego G. Diel
168 [GO] 2023―Sep―27 Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients Yael Rosenberg-Hasson, Tyson H. Holmes, Joann Diray-Arce, Jing Chen, Ryan Kellogg, Michael Snyder, et al. (+5)
169 [GO] 2023―Aug―10 Alteration of metabolite landscape in hypoxia replicates immune cell programs indicative of dysfunctional immunity in severe COVID-19 Elizabeth A Thompson, Laila Stoddart, Wabathi Ngecu, Katherine Cascino, Andrew H. Karaba, Andrea L. Cox
170 [GO] 2023―Aug―10 Localized immune dysregulation is associated with lung injury in severe pediatric COVID-19 Rebecca C Korenberg, Joseph N Bell, Marissa C Bradley, Thomas J Connors
171 [GO] 2023―Aug―10 Long-term metabolomic alterations during post-acute sequelae of COVID-19 Andrea C Wong, Ashwarya Devason, Iboro C Umana, Timothy Cox, Lenka Dohnalová, Nuala J Meyer, et al. (+4)
172 [GO] 2023―Aug―10 Robust T cell responses to the Pfizer/BioNTech vaccine compared to infection and evidence of attenuated CD8+ T cell responses due to COVID-19 Fei Gao, Vamsee Mallajoysula, John D Altman, Taia T Wang, Kari C Nadeau, Scott D Boyd, et al. (+2)
173 [GO] 2023―Aug―10 Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 Paoline Laurent, Chao Yang, Andre L Rendeiro, Benjamin Nilsson-Payant, Lucia Carrau, Vasuretha Chandar, et al. (+6)
174 [GO] 2023―Aug―10 Spleen tyrosine kinase inhibition restores neutrophil homeostasis in COVID-19 Gustaf Wigerblad, Seth Warner, Marcos Ramos-Benitez, Lela Kardava, Xin Tian, Rui Mao, et al. (+16)
175 [GO] 2023―Aug―10 Paradoxically Increased Inflammation in Immunosuppressed Individuals with COVID-19 James Oscar Moore-Stanley, Sean Blandin Knight, Nawar Bakerly, Sara Kirkham, Thomas Williams, Tracy Hussell
176 [GO] 2023―Aug―10 Dysregulated immune networks define distinct respiratory phenotypes of post-acute sequelae of COVID-19 Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, Jeffrey Sturek, Catherine Bonham, Deborah Murphy, et al. (+7)
177 [GO] 2023―Aug―10 Immune Regulatory Markers in Clinical Cases of COVID-19 Charitha Madiraju, Chandra Shekar Mallarpu, Srinivasa Ikswaja Chelluri, Maneendra Singarapu, Tapaswi Krishna, Lakshmi Kiran Chelluri
178 [GO] 2023―Aug―10 Enhancing immunology based health sciences education for addressing health inequities - in the context of COVID-19 Dianne Sika-Paotonu
179 [GO] 2023―Aug―10 Vaccine Immunology in the context of COVID-19 Dianne Sika-Paotonu
180 [GO] 2023―Aug―10 Viral immunology in the context of COVID-19 Dianne Sika-Paotonu
181 [GO] 2023―Aug―10 Anti-SARS-CoV-2 IgG levels are associated with circulating levels of chemokines CXCL9/CXCL10 and severity disease, but not with RBD-specific B cells 4 months after COVID-19 Romina Andrea Quiroga, Sergio Andrés Sanhueza Novoa, Camilo Daniel Cabrera-Garcia, Bárbara Evelyn Antilef Cáceres, Camila Paz Munoz, Faryd Llerena, et al. (+6)
182 [GO] 2023―Aug―10 Cardiac dysfunction mediators CXCL-9 and chemotaxis of phagocytes characterized patients with long-term pulmonary dysfunction after COVID-19. Sergio Andrés Sanhueza Novoa, Estefania Nova-Lamperti, Camilo Daniel Cabrera-Garcia, Romina Andrea Quiroga, Camila Paz Muñoz Grez, Bárbara Evelyn Antilef Cáceres, Gonzalo Labarca
183 [GO] 2023―Aug―10 Investigating links between persistent symptoms after COVID-19 and longitudinal changes in memory T cell responses to EBV, CMV, HSV-1, and SARS-CoV-2. Jiabao Zhong, Erika L Smith, Christina S McConney, David J Bean, Anna C Belkina, Jennifer E Snyder-Cappione
184 [GO] 2023―Aug―10 Characterization of CD8 +T cells recognizing a dominant epitope of SARS-CoV-2 spike protein in COVID-19 convalescent, vaccinated, and unexposed individuals Ainslee J Zou, Jiangyuan Li, Cecily Choy, Joseph Chen, Humza Hemani, Beverly Baptiste, et al. (+13)
185 [GO] 2023―Aug―10 Understanding of SARS-CoV-2 pathogenicity in COVID-19 cynomolgus macaque model and consideration of its reinfection Emiko Urano, Tomotaka Okamura, Yasuhiro Yasutomi
186 [GO] 2023―Aug―10 Critical COVID-19 disease explained by type I interferon autoantibodies found in patients within the Military Health System. Maria A Leondaridis, Debra Yee, Marana Tso, Elana Shaw, Lindsey B. Rosen, Emily Samuels, et al. (+25)
187 [GO] 2023―Aug―10 Non-fatal outcomes of COVID-19 disease in children with solid organ transplants associates with down-regulation of senescent pathways Kumar Subramanian, Ivy Tesfai, Vinona Muralidaran, Christina Seeley, Lauren Corbert, Nada Yazigi, et al. (+7)
188 [GO] 2023―Aug―10 Epigenetic Memory of COVID-19 in Innate Immune Cells and Their Progen-itors-- Jin Gyu G Cheong
189 [GO] 2023―Aug―10 Role of IgG glycans in severe COVID-19 inflammatory cytokine responses Erin M. Scherer, Jacob D. Sherman, Vinit Karmali, Bhoj Kumar, Trevor W. Simon, Sarah Bechnak, et al. (+15)
190 [GO] 2023―Aug―10 Multi-omic spatial profiling in COVID-19 lung revels temporal evolution of the disease and novel collagen VI biomarker for outcome Matthew R Pugh, Éanna Fennel, Ciara Leahy, Aisling M. Ross, Gary Reynolds, Tracey Perry, et al. (+4)
191 [GO] 2023―Aug―10 Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, et al. (+6)
192 [GO] 2023―Aug―10 Correlates of COVID-19 mRNA vaccine humoral immune responses in men living with HIV-1 Dylan J. Tuttle, Priscila M. S. Castanha, Amro Nasser, Maris S. Wilkins, Deirdre E. Cuff, Prabal Chhibbar, et al. (+5)
193 [GO] 2023―Aug―10 Boosting location of COVID-19 mRNA vaccine regulates the germinal center reaction Wenxia Jiang, Xue Yuan, Scott Renshaw, Wei Luo
194 [GO] 2023―Aug―10 Antibody response of Comirnaty vaccine in different immunocompromised groups during the COVID-19 pandemic Khongorzul Togoo, Burenjargal Batmunkh, Nomin-Erdene Tsogtbayar, Ulziisaikhan Batmunkh, Enkhtuya Selenge, Khuselt-Od Togtokhbaatar, et al. (+4)
195 [GO] 2023―Aug―10 New Complement Dependent Cytotoxicity Assay and its application to COVID-19 patient sera harboring anti-lymphocyte antibodies. Stephanie Calderon, Xiangdong Liu, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew Memoli, et al. (+5)
196 [GO] 2023―Aug―10 Prevalence and complement activation of anti-lymphocyte IgM antibodies in hospitalized COVID-19 patients Ainhoa Perez-Diez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, et al. (+7)
197 [GO] 2023―Aug―10 Hospitalized COVID-19 patients exhibit increased numbers of low density neutrophils expressing the transcription factor ARID3a Carol F Webb, James A. Hocker, Malini A. Shankar, John Leland Booth, Lauren A. Sinko, Wenxin Wu, Jordan Metcalf
198 [GO] 2023―Aug―10 Patients who develop insulin resistance 4-months post-COVID-19 exhibited higher NETosis and miR-21-5p expression than COVID-19 patients without metabolic alterations. Camilo Daniel Cabrera-Garcia, Romina Andrea Quiroga, Sergio Andrés Sanhueza Novoa, Bárbara Evelyn Antilef Cáceres, Camila Paz Muñoz Grez, Marco Fraga, et al. (+10)
199 [GO] 2023―Aug―10 Infiltrative monocyte derived adenosine deaminase 2 is associated with COVID-19 related acute respiratory distress syndrome Silpa Tiwari-Heckler, Lisa Vierbaum, Uta Merle, Zhenghui Gordon Jiang
200 [GO] 2023―Aug―10 Inflammatory and immune response signatures associated with COVID-19 severity David S Gibson, Joseph McLaughlin, Darren McDaid, Seodhna Lynch, Maurice OKane, Martin Kelly, et al. (+8)
201 [GO] 2023―Aug―10 Metabolic profiling of COVID-19 severity and mortality: A targeted metabolomics approach Farhan S Cyprian, Asmaa Doudin, Malkan Khatib, Mohamed Elrayess, Hadi Yassine, Abdallah Musa
202 [GO] 2023―Aug―10 Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform. Chang-Yuil Kang, Soojeong Chang, Kwang-Soo Shin, In Kyung Jung, Hyemin Park, Jonghan Oh, et al. (+3)
203 [GO] 2023―Aug―10 Relatively preserved functional capacity with standard COVID-19 vaccine regimen in People Living with HIV asymptomatic or with mild immunodeficiency Sung-Han Hsiao, Chen-Yiu Hung, Chung-Guei Huang, Tse-Ching Chen, Chia-Shiang Chang, Yu-Lin Huang, et al. (+4)
204 [GO] 2023―Aug―10 Investigating a Role for Eosinophils in the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Maryonne Snow-Smith, Paul J Baker, Andrea C Bohrer, Ehydel Castro, Flor Torres-Juarez, Charles F Anderson, et al. (+4)
205 [GO] 2023―Aug―10 Cross-reactive seasonal coronavirus antibody responses contribute to antibody-mediated effector functions against SARS-CoV-2 in individuals in Kenya. Sinem Ulusan, Shuangyi Bai, Amelie Murrell, Eric Osoro, Jeanette Dawa, Isaac Ngere, et al. (+5)
206 [GO] 2023―Aug―10 Coronavirus spike protein vaccination history affects SARS-CoV-2 receptor-binding domain-specific memory response in a mouse model David Brice, Maureen A McGargill
207 [GO] 2023―Aug―10 Hexavalent coronavirus vaccine elicits both humoral and cellular immune responses in mice Stina Gröhn, Saana Soppela, Alina Iakubovskaia, Arja Pasternack, Vili Lampinen, Olli Ritvos, Minna Hankaniemi
208 [GO] 2023―Aug―10 A case for teaching basic immunology through scientific journalism-lesson taught by a Coronavirus went viral! Nadeem Fazal, Jassam Alsiyaghy, Kirubel Eshetie, Kiara D Wilson, Mohammad Newaz, Hafeez Faridi, et al. (+4)
209 [GO] 2023―Aug―10 Cytotoxic T cells targeting spike glycoprotein are associated with hybrid immunity to SARS-CoV-2 Jolie M Phan, Erik D. Layton, Krystle K.Q. Yu, Melissa S. Aguilar, Inah Golez, Nicholas M. Franko, et al. (+7)
210 [GO] 2023―Aug―10 Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2 Dennis Lapuente, Vera Viherlehto, Jana Fuchs, Jonas Willar, Ana V Antao, Valentina Eberlein, et al. (+18)
211 [GO] 2023―Aug―10 Intramuscular mRNA prime plus intranasal adenoviral vector booster elicit robust respiratory mucosal IgA responses against SARS-CoV-2 Jinyi Tang, Yue Wu, Cong Zeng, Justin J. Taylor, Guizhi Zhu, Drew Weissman, et al. (+2)
212 [GO] 2023―Aug―10 A rationally designed combined intranasal adjuvant drives robust and broad humoral, cellular, and mucosal immune responses to SARS-CoV-2 Pamela T Wong, Sonia Jangra, Jeffrey J Landers, Gabriel Laghlali, Raveen Rathnasinghe, Jessica J O’Konek, et al. (+4)
213 [GO] 2023―Aug―10 Intranasal delivery of adenovirus-vectored vaccine confers protective mucosal immunity against SARS-CoV-2 Hi Eun Jung, Keun Bon Ku, Byeong Hoon Kang, Kyun-Do Kim, Heung Kyu Lee
214 [GO] 2023―Aug―10 Antigen presenting cell targeted T cell DNA vaccine inducing strong and specific cellular responses across multiple T cell epitopes of SARS-COV-2 Gunnstein Norheim, Katarzyna Kuczkowska, Elisabeth Stubsrud, Louise Bjerkan, Marthe Jørgensen, Hannah Husbyn, et al. (+13)
215 [GO] 2023―Aug―10 Studies in humans and mice reveal a critical role for CCR2 in trafficking of pDCs during infection with SARS-CoV-2 Howard H Zhang, Xinping Lu, Davis Garner, Farhat Parween, Satya Singh, Shamik Majumdar, et al. (+13)
216 [GO] 2023―Aug―10 A new mouse model expressing human ACE2, TMPRSS2, and FCGRT for evaluating human antibody responses to SARS-CoV-2 Fernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, Robyn Miller, Chris Conner, Kathryn M Hastie, et al. (+5)
217 [GO] 2023―Aug―10 Fast Preparation of Peptide Tools to address new emerging Viruses: Case example SARS-CoV-2 Aaron Castro, S Pfeil, Pavlo Holenya, Ulf Reimer, Tobias Knaute, Jonny Zerweck, et al. (+6)
218 [GO] 2023―Aug―10 The Serological Sciences Network (SeroNet); the U.S. government’s effort to boost testing capacity and escalate standardized research on immune responses to SARS-CoV-2 Nancy V Roche, Tom Hickey, Elaine Freund, Patrick Breads, Heidi Hempel, Michelle Berny-Lang, et al. (+5)
219 [GO] 2023―Aug―10 Identifying Epitope Sites on the Receptor Binding Domain (RBD) of SARS-CoV-2 Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, Lisa F. Byod, Kannan Natarajan, Martin Meier-Schellersheim, David H Margulies
220 [GO] 2023―Aug―10 Calming the storm: Immunoregulatory receptor NLRX1 and its role in the immune response to SARS-CoV-2 Hannah Ivester, Mackenzie Woolls, Holly A Morrison, Juselyn D Tupik, Christina Chuong, Carla Finkielstein, et al. (+3)
221 [GO] 2023―Aug―10 SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters. Michael Schotsaert, Juan Garcia-Bernalt Diego, Gagandeep Singh, Sonia Jangra, Adolfo Garcia-Sastre, Manon Laporte, et al. (+10)
222 [GO] 2023―Aug―10 SARS-CoV-2 and SARS-CoV-2 Spike protein S1 subunit Trigger Proinflammatory Response in Macrophages in the Absence of Productive Infection Lindsay Grace Miller, Kim Chiok, Santanu Bose, Tanya A. Miura
223 [GO] 2023―Aug―10 Spike protein vaccine triggers systemic Th2 and Th17 inflammatory responses and pulmonary immunopathology following SARS-CoV-2 breakthrough infection Tianyi Zhang, Nicholas Magazine, Michael C. McGee, Pius Babawale, Sarah Upshaw, Mariano Carossino, et al. (+3)
224 [GO] 2023―Aug―10 The immunodominant SARS-COV-2 CD8 +T cell repertoire is capable of resisting antigenic drift Michael J Malone, Yuwan Guo, Laura Su, Jenny Jiang
225 [GO] 2023―Aug―10 Ackr1-deficient mice are protected from lethal SARS-CoV-2 challenge Shamik Majumdar, Sergio M Pontejo, Joseph Weaver, Philip M Murphy
226 [GO] 2023―Aug―10 SARS-CoV-2 Delta requires human ACE2 but not human TMPRSS2 to infect mice and elicits greater lung injury and adaptive immune response than Omicron in human ACE2 knock-in mice Shailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Norazizah Shafee, Julia Timis, Erin Maule, Robyn Miller, et al. (+7)
227 [GO] 2023―Aug―10 Age-associated variations in anti-spike antibody responses in mild SARS-CoV-2 disease. Emily Parsons, Stephanie Richard, Eric Laing, Anthony Fries, Jeffrey Livezey, Milissa Jones, et al. (+21)
228 [GO] 2023―Aug―10 The extracellular tail of IFITM3 promotes SARS-CoV-2 entry into cells and is diversifying in primates Alex A Compton, Tiansheng Li, Guoli Shi, Kin Kui Lai, Nelly Mak, Abigail Jolley, et al. (+3)
229 [GO] 2023―Aug―10 SARS-CoV-2 Envelope Protein Tolerizes Macrophage Response to Secondary Inflammatory Stimuli Stephen H Pierce, Rebecca Mclennan, Santosh Khanal, Heather Menden, Vankatesh Sampath, Todd Bradley
230 [GO] 2023―Aug―10 Peering into the future of SARS-CoV-2 evolution using a computational model of the SARS-CoV-2 serum antibody repertoire Liel Cohen-Lavi, Eilay Koren, Yan Yegorov, Sinai Sacharen, Anat Burkovitz, Tomer Hertz
231 [GO] 2023―Aug―10 mRNA vaccination induces persistent pharyngeal mucosal B cell responses to SARS-CoV-2 in children Qin Xu, Pamela Mudd, Hengameh Behzadpour, Daniel Newman, Lorenza Bellusci, Gabrielle Grubbs, et al. (+9)
232 [GO] 2023―Aug―10 Unraveling the cell death induced by SARS-CoV-2 in lung epithelial cells Kaixin Liang, Katherine Camille Barnett, Yuying Xie, Thomas Oguin, Gregory D Sempowski, Yu Leo Lei, Jenny P Ting
233 [GO] 2023―Aug―10 Dysregulated myeloid cell activity is associated with fatal disease in SARS-CoV-2 infected aged mice Debarati Chanda, Roshan Ghimire, Rudragouda Channappanavar, Matthias Mack
234 [GO] 2023―Aug―10 Immunoregulatory Roles of TGF-β and IL-4 during Mouse-adapted SARS-CoV-2 Infection Solomon Taye Sima, Lucinda Puebla-Clark, Maria Gonzalez-Orozco, Thomas R Shelite, Hannah G Federman, Matthew B Huante, et al. (+8)
235 [GO] 2023―Aug―10 Amniotic fluid derived extracellular vesicles as novel anti-inflammatory therapeutics against SARS-CoV-2 infection Debarati Chanda, Michael A. Bellio, Tania del Rivero, Maria Ines Mitrani, Rudragouda Channappanavar
236 [GO] 2023―Aug―10 IL-33 promotes inflammatory responses and exacerbates lung pathology in a mouse model of SARS-CoV-2 infection Yuejin Liang, Hui Wang, Yashoda Madaiah Hosakote, Casey Gonzales, Xuping Xie, Pei-Yong Shi, et al. (+3)
237 [GO] 2023―Aug―10 Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection. John T Bates, Seth T. Lirette, Andrew P. Farmer, Michael A. Bierdeman, Kristina B. Seyfarth, Denise D. Montgomery, et al. (+3)
238 [GO] 2023―Aug―10 Bi-directional epithelial-immune communication amplifies inflammasome activation and IL-6 release during SARS-CoV-2 infection Katherine Camille Barnett, Yuying Xie, Takanori Asakura, Dingka Song, Kaixin Liang, Sharon A. Taft-Benz, et al. (+12)
239 [GO] 2023―Aug―10 High Mobility Group Box 1: A Predictive Biomarker of Aberrant Humoral Responses Implicated in Post-Acute Sequelae of SARS-CoV-2 Infection Noelle C Rubas, Rafael Aniu Peres-David, Braden P Kunihiro, Krit Phankitnirundorn, Trevor McCraken, Lesley Umeda, et al. (+2)
240 [GO] 2023―Aug―10 Interferon-lambda accelerates viral clearance and regulates CD8 +T cells immunity in a murine model of SARS-CoV-2 infection Abigail Solstad, Adam D Kenney, Najmus Sahar Mahfooz, Ashley Zani, Jeffrey Kawahara, Richard T Robinson, et al. (+3)
241 [GO] 2023―Aug―10 Inhibited MHC Class I and MHC Class II antigen processing and presentation upon Sars-CoV-2 infection Padma Pandurang Nanaware, John Cruz, Muneeruddin Khaja, Scott A Shaffer, Lawrence Stern
242 [GO] 2023―Aug―10 Phenotypical and Functional Characterization of Unswitched Memory B cells verses Switched during SARS-CoV-2 Infection Moriah J Castleman, Adriana Luna Santos, Kelsey Lesteberg, James Maloney, William Janssen, Kara Mould, et al. (+3)
243 [GO] 2023―Aug―10 Role of HMGB1 in the activation of innate immune responses during SARS-CoV-2 infection Yashoda Madaiah Hosakote, Kempaiah Rayavara, Yuejin Liang, Corri B Levine, Scott C Weaver, Bill T Ameredes, et al. (+4)
244 [GO] 2023―Aug―10 Persistent CD4 T cell functional deficits in individuals recovered from prolonged symptomatic SARS-CoV-2 infection Susan Kovats, Christina Lawrence, Sean Turner, Nathan Pezant, Nancy Redinger, Carla Guthridge, et al. (+4)
245 [GO] 2023―Aug―10 SARS-CoV-2 infection and Spike protein exposure alter iPSC-derived human brain organoid homeostasis. Gioia Cappelletti, Lorenzo Brambilla, Valentina Melzi, Mafalda Rizzuti, Monica Nizzardo, Daria Trabattoni, et al. (+3)
246 [GO] 2023―Aug―10 Multiplex assays to determine correlation of binding and neutralizing antibodies following SARS-CoV-2 infection and vaccination Neeraja Venkateswaran, Jawad Sarwar, William Max Nelson, Kodumudi S Venkateswaran
247 [GO] 2023―Aug―10 Longitudinal analysis of the LA-SPARTA cohort of high-risk individuals after SARS-CoV-2 infection and vaccination Meagan M Jenkins, Donna Phan Tran, Evelyn A Flores, Deborah Kupferwasser, Harry Pickering, Ying Zheng, et al. (+6)
248 [GO] 2023―Aug―10 IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting early ACE2-mediated events Vadim I Pivniouk, Oksana Pivniouk, Jennifer Uhrlaub, Allyson Molzahn, Hiroki Kimura, Julie Ledford, et al. (+3)
249 [GO] 2023―Aug―10 Neutrophilia and neutrophil-derived extracellular traps as innate immune markers of SARS-CoV-2 infection in a feline animal model Sachithra J Gunasekara, Breya Ludwig, Shannon Cowan, Miruthula Tamil Selvan, Jerry Ritchey, Craig Miller, Jennifer Rudd
250 [GO] 2023―Aug―10 Longitudinal analysis reveals age-dependent immune responses to SARS-CoV-2 infection in a mouse model Wei Qian, Xiaoqin Wei, Barbara J Mann, Jie Sun
251 [GO] 2023―Aug―10 IL-10 promotes tissue-resident memory T cells (T RM) in the respiratory tract during SARS-CoV-2 infection in rhesus macaques Christine Nelson, Taylor Foreman, Sivaranjani Namasivayam, Keith Kauffman, Felipe Gomez, Shunsuke Sakai, et al. (+4)
252 [GO] 2023―Aug―10 Vaccination prior to SARS-CoV-2 infection reduces autoreactive antibody induction Chun-Yang Lin, Ashley Castellaw, David Brice, Stacey Schultz-Cherry, Paul Thomas, Josh Wolf, Maureen McGargill
253 [GO] 2023―Aug―10 Autoantibodies produced by SARS-CoV-2 infection trigger damage to the lacrimal and salivary glands and lead to the development of Sjögren’s Disease Yiran Shen, Alexandria Voigt, Laura Goranova, Mehdi Abed, David Kleiner, Jose Maldonado, et al. (+8)
254 [GO] 2023―Aug―10 Improved control of SARS-CoV-2 infection with nucleocapsid-specific antibodies Pablo A Penaloza-MacMaster, Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle Richner, Lavanya Visvabharathy, et al. (+6)
255 [GO] 2023―Aug―10 The emergence of SARS-CoV-2 lineages and associated antibody responses among asymptomatic individuals in a large university community Marlena Rae Merling, Najmus Mahfooz, Richard T Robinson
256 [GO] 2023―Aug―10 Baseline HMGB-1 Concentrations Are Predictive of Neutralization Efficacy after SARS-CoV-2 mRNA Vaccination Lesley K Umeda, Braden P Kunihiro, Noelle C Rubas, Riley K Wells, Krit Phankitnirundorn, Rafael Aniu Peres-David, Alika K Maunakea
257 [GO] 2023―Aug―10 Anamnestic expansion of Omicron-reactive CD8 +T cells after booster SARS-CoV-2 mRNA vaccination across different immunocompromised states Thomas R Müller, Takuya Sekine, Darya Trubach, Julia Niessl, Anna Olofsson, Yu Gao, et al. (+11)
258 [GO] 2023―Aug―10 CD8 +T-cell memory induced by SARS-CoV-2 mRNA vaccination is maintained by clonal replenishment Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, Shigeyuki Shichino, Atsushi Hara, Noriko Ouji-Sageshima, et al. (+3)
259 [GO] 2023―Aug―10 Design and Preclinical Evaluation of a Universal SARS-CoV-2 mRNA Vaccine Laura Katherine Langston, Renhuan Xu, Huabin Zhu, Jane Qin, Ju Jeon, Jiangsheng Xu, Stephanie Mou
260 [GO] 2023―Aug―10 Altered antibody profiles after receipt of third dose SARS-CoV-2 mRNA vaccines in solid organ transplant recipients Jenny MinChen Lee, Janna R. Shapiro, John S. Lee, Ioannis Sitaris, Stephanie R. Peralta, Maggie Li, et al. (+7)
261 [GO] 2023―Aug―10 Investigating SARS-CoV-2 ORF3a binding to human TRAF2 and TRAF3 Brianna M. Busscher, Henock Befekadu, Zhonghua Liu, Chuanping Wang, Tsan Sam Xiao
262 [GO] 2023―Aug―10 Correlates of immunity in SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet, Carol Weiss, Cara Olsen, John Powers, Si’Ana Coggins, David Tribble, et al. (+29)
263 [GO] 2023―Aug―10 SARS-CoV-2 RBD-specific atypical memory B cells exhibit effector memory-like features in multi-dose mRNA vaccination Jeongsoo Lee, Sung-Han Kim, Eui-Cheol Shin, Su-Hyung Park
264 [GO] 2023―Aug―10 Modeling the SARS-CoV-2 receptor ACE2 indicates that protein-bound Zn affects distant protein stability and interactions Peter R Fatouros, Urmi Roy, Shantanu Sur
265 [GO] 2023―Aug―10 SARS-CoV-2 seroreversion is associated with a decrease in T cell functionality in children Megan A Files, Leanne Kehoe, Amanda Adler, Janet Englund, Chetan Seshadri
266 [GO] 2023―Aug―10 Clonal dynamics of SARS-CoV-2 specific CD4 T cells in lymph nodes after vaccination laurent Bartolo, Yi-Gen Pan, Sumbul Afroz, Laura Su
267 [GO] 2023―Aug―10 Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge Gina Cusimano, Ebony N. Gary, Nicholas J Tursi, Bryce M Warner, Jennifer Connors, Elizabeth M Parzych, et al. (+17)
268 [GO] 2023―Aug―10 Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial susan johnson, Clara B Jegede, Samanta Gutierrez, Susan Greco, James Cummings, Keith A Gottlieb, Sean N Tucker
269 [GO] 2023―Aug―10 Role of germinal center response in the antibody responses against SARS-CoV-2 spike protein Jumana A T Khalil, Kosuke Miyauchi, Yuichiro Yamamoto, Kohji Noguchi, Kazuo Takayama, Masato Kubo
270 [GO] 2023―Aug―10 Roles of glycosylation and redox states on SARS-CoV-2 spike protein actions Jennyfer Bejoy, Tinatin I. Brelidze, Yuichiro J. Suzuki
271 [GO] 2023―Aug―10 Genetic immunization with self-assembling SARS-CoV-2 Spike-HBsAg nanoparticles Jonah S Merriam, Catherine Liu, Lingshu Wang, Wei Shi, Eun-Sung Yang, Yi Zhang, et al. (+14)
272 [GO] 2023―Aug―10 Fc properties of SARS-CoV-2 spike-specific antibodies elicited by vaccines and infection Catarina E Hioe, Jeromine Klingler, Juan Bandres, Rozita Emami-Gorizi, Fatima Amanat, Shreya Kowdle, et al. (+5)
273 [GO] 2023―Aug―10 Development and Characterization of a novel humanized ACE2 mouse model to study the pathogenesis of viral lung infection by variable SARS-CoV-2 strains Chang-Yong Choi, Jason Villano, Andy Pekosz, Hongpeng Jia
274 [GO] 2023―Aug―10 Prior infection exposure alters the immune response at homeostasis and following SARS-CoV-2 vaccination and experimental infection in laboratory mice. Victoria Kate Baxter, Audrey C. Knight, Jacob A. Dillard, Elizabeth J. Anderson, Katia D. Pressey, Brea K. Hampton, et al. (+7)
275 [GO] 2023―Aug―10 Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection Cody Lauritsen, Ivy Trinh, Srushti Desai, Erin Clancey, Amelie Murrell, Saraswatie Rambaran, et al. (+14)
276 [GO] 2023―Aug―10 Intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate confers potent mucosal and systemic immunity and protection Awadalkareem Adam, Birte K Kalveram, Jing Zou, Leslie Rodriguez, Ankita Singh, John Yun-Chung Chen, et al. (+3)
277 [GO] 2023―Aug―10 A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response. Stephen Anderson, Elliot Campbell, Julie Dobkin, Louis Osorio, Afsal Kolloli, Santhamani Ramasamy, et al. (+4)
278 [GO] 2023―Aug―10 Insufficient epitope specific T cell clones is responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in the elderly Chanchan Xiao, Guobing Chen
279 [GO] 2023―Aug―10 SARS-CoV-2 Vaccine-Elicited Antibody Responses in Breastmilk Caitlin Williams, Mackensie Gross, Savannah Herbek, Sallie Permar, Yawei Yang
280 [GO] 2023―Aug―10 Omicron Breakthrough Infection Elicits Superior Humoral and Mucosal Immunity to SARS-CoV-2 Variants than Booster Doses Sabryna Nantel, Salma Sheikh-Mohamed, Gary Chao, Queenie Hu, Alexandra Kurtesi, Heidi Wood, et al. (+9)
281 [GO] 2023―Aug―10 Mucosal chemokine adjuvant supports heterologous protection against Delta and Omicron VOCs in the context of a SARS-CoV-2 wild-type DNA vaccine Ebony Nicole Gary, Nicholas J Tursi, Bryce M Warner, Elizabeth M Parzych, Ali R Ali, Drew Frase, et al. (+9)
282 [GO] 2023―Aug―10 Differential role of TLR7 signaling in SARS-CoV-2-induced antiviral and inflammatory responses Roshan Ghimire, Titus Patton, Rakshya Shrestha, Debarati Chanda, Sunil More, Rudragouda Channappanavar
283 [GO] 2023―Aug―10 Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc Shie-Liang Hsieh
284 [GO] 2023―Aug―10 Pre-existing SARS-CoV-2-reactive CD4 +T cells are established and highly functional in early childhood Anna Olofsson, Marion Humbert, Julia Niessl, Emma Hodcroft, Yu Gao, Ebba Sohlberg, et al. (+7)
285 [GO] 2023―Aug―10 Design and Characterization of Bivalent Molecules Against SARS-CoV2 Javeed dhobi Ahmad, Jiansheng Jiang, Richard W. Perks, Bernard Lafont, Tracey Burdette, Johnson Reed, et al. (+4)
286 [GO] 2023―Aug―10 SARS-CoV2 Decreases Human Beta-Defensin-1 and FoxI1 in the Oral Cavity Without Affecting CFTR Lisa K Ryan, Weston J. Barney, Paige K. Tierney, Jumin S. Kim, Tanya O. Robinson, Neha S. Dhaliwal, et al. (+2)
287 [GO] 2023―Aug―10 NF-κB signaling promotes SARS-CoV2 infection in human lung epithelial cells Zienab Etwebi, Kasirajan Ayyanathan, Jesse Miller, Brinda Kamalia, Minghua Li, Jae Seung Lee, et al. (+8)
288 [GO] 2023―Aug―10 Pandemic preparedness: Addition of TLR agonists CpG+MPLA to emulsified H5 confers protection against H5N1 challenge after a single dose. Jenny E Davies, Michael Hwang, Emmanuel Dollinger, Jiin Felgner, Aarti Jain, Qing Nie, et al. (+3)
289 [GO] 2023―Aug―10 Immune system perturbations in patients with severe long COVID Lucie Rodriguez, Ziyang Tan, Tadepally Lakshmikanth, Jun Wang, Hugo Barcenilla, Laura Gonzalez, et al. (+8)
290 [GO] 2023―Aug―09 Intestinal IL-1β Plays a Role in Protecting against SARS-CoV-2 Infection Jöran Lücke, Fabian Heinrich, Jakob Malsy, Nicholas Meins, Josa Schnell, Marius Böttcher, et al. (+21)
291 [GO] 2023―Jul―26 Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2 Hong Yu, Liam J. Worrall, Thorsten Berger, Martin Petric, Bryan H. Lin, Marija Vuckovic, et al. (+25)
292 [GO] 2023―Jul―03 Considerations for Choosing T Cell Assays during a Pandemic Jaclyn C. Law, Tania H. Watts
293 [GO] 2023―Jun―16 Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, Jaclyn C. Law, Gary Y. C. Chao, Daniel Pereira, et al. (+20)
294 [GO] 2023―Jun―02 SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor Nicole O. Ponde, Karsen E. Shoger, Mst Shamima Khatun, Mrinal K. Sarkar, Ipsita Dey, Tiffany C. Taylor, et al. (+6)
295 [GO] 2023―May―05 Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19 Ramesh K. Paidi, Malabendu Jana, Sumita Raha, Rama K. Mishra, Brian Jeong, Monica Sheinin, Kalipada Pahan
296 [GO] 2023―Apr―26 Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge Fábio Mambelli, Fábio V. Marinho, Juvana M. Andrade, Ana C. V. S. C. de Araujo, Rodrigo P. F. Abuna, Victor M. R. Fabri, et al. (+11)
297 [GO] 2023―Apr―12 Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19 Heejin Nam, June-Young Koh, Jae Hyung Jung, Hyeongseok Jeong, Hye Won Jeong, Shinhye Cheon, et al. (+3)
298 [GO] 2023―Mar―24 Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2 Jolie M. Phan, Erik D. Layton, Krystle K. Q. Yu, Melissa S. Aguilar, Inah Golez, Nicholas M. Franko, et al. (+7)
299 [GO] 2023―Mar―07 Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology Mohamed M. Shamseldin, Adam Kenney, Ashley Zani, John P. Evans, Cong Zeng, Kaitlin A. Read, et al. (+14)
300 [GO] 2023―Feb―13 Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination Michael Quinn, Luis Parra-Rodriguez, Wafaa B. Alsoussi, Chapelle Ayres, Michael K. Klebert, Chang Liu, et al. (+11)
301 [GO] 2023―Feb―07 SARS-CoV-2 spike binding peptides: A potential therapeutic approach for COVID-19 Santhamani Ramasamy, Siddiqui Zain, Abhishek Roy, Ranjeet Kumar, Afsal Kolloli, Theresa Li-Yun Chang, et al. (+2)
302 [GO] 2023―Feb―07 Profound phenotype alteration and delayed regeneration of circulating antigen presenting cells in COVID-19 Elena Winheim, Linus Rinke, Konstantin Lutz, Anna Reischer, Maximilian Münchhoff, Johannes Hellmuth, et al. (+3)
303 [GO] 2023―Feb―07 Phosphatidylserine Receptor Enhancement of SARS-CoV-2 Entry: AXL as a Therapeutic Target for COVID-19 Dana Bohan, Hanora Van Ert, Kai Rogers, Natalie Ruggio, Roberth Anthony Rojas Chávez, Tomasz Stokowy, et al. (+6)
304 [GO] 2023―Feb―07 Designing a bispecific antibody targeting IL-6Rα and NKG2A receptors via in silico affinity maturation as a strategy to combat severe COVID-19 Manusmriti Agarwal, Samvedna Saini, Spandan Kaushik, Aakanksha Prasad, Yatender Kumar
305 [GO] 2023―Feb―07 Development of a gp96-Ig vaccine for COVID-19 Natasa Strbo, Eva Fisher, Laura Padula, Katelyn Elizabeth O’Neill
306 [GO] 2023―Feb―07 TVGN-489: A novel approach for the production of SARS-CoV-2-specific cytotoxic T lymphocytes to treat COVID-19 Neal Flomenberg, John Lyle Wagner, Yuri Sykulev, Nadezhda Anikeyeva, Yanping Huang, Michael Sun, et al. (+12)
307 [GO] 2023―Feb―07 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 Lauren Barbara Rodda, Jason Netland, Laila Shehata, Kurt B. Pruner, Peter A. Morwaski, Christopher D. Thouvenel, et al. (+18)
308 [GO] 2023―Feb―07 Lupus-like extrafollicular B cell responses and autoreactivity are hallmarks of severe COVID-19 Matthew C Woodruff, Richard P Ramonell, F. Eun-Hyung Lee, Ignacio Sanz
309 [GO] 2023―Feb―07 Virtual graduate immunology and immunotherapy education during COVID-19 Rosalie Sterner, Karen E Hedin
310 [GO] 2023―Feb―07 Diverse Functional Autoantibodies that Underlie Immune Perturbations in COVID-19 Tianyang Mao, Eric Y. Wang, Jon Klein, Yile Dai, John D. Huck, Feimei Liu, et al. (+25)
311 [GO] 2023―Feb―07 A single center, double blind, randomized, placebo controlled trial of anakinra in adult patients with features of Cytokine Storm Syndrome in COVID-19 Randy Q Cron, Lesley E Jackson, Nitasha Khullar, Christopher A Chapleau, W Winn Chatham
312 [GO] 2023―Feb―07 COVID-19 affected “face to face” interaction with the professors. Lessons learned from traditional learning. Sandra R Olk, Ryan Stempek, Sahira Renteria, Nadeem Fazal
313 [GO] 2023―Feb―07 DOCK8 mutations in COVID-19 and MIS-C Cytokine Storm Syndrome Randy Q Cron, Mingce Zhang, Remy R Cron, Devin Absher, John M Bridges, Amanda Schnell, et al. (+6)
314 [GO] 2023―Feb―07 Optimizing immunoassay-based selection of donors for COVID-19 convalescent plasma Hanora A Van Ert, Kai Rogers, Dana Bohan, Chanze Han, Spencer Dempewolf, Kristina Sevcik, et al. (+9)
315 [GO] 2023―Feb―07 HLA allele frequencies and susceptibility analysis in 94 Florida residents with COVID-19 disease Yiran Shen, Cuong Q Nguyen, David A Ostrov
316 [GO] 2023―Feb―07 Distinct peripheral inflammatory profiles distinguish COVID-19 from influenza infection, with limited contributions from cytokine storm Jeremy Chase Crawford, Philip A. Mudd, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, et al. (+13)
317 [GO] 2023―Feb―07 Patient-reported comorbidity affects symptom duration in non-hospitalized patients with mild to moderate COVID-19 in a clinical study John P Haran, Yan Zheng, Norma Alonzo-Palma, Mark Wingertzahn
318 [GO] 2023―Feb―07 Frequency and phenotype of SARS-CoV-2-specific CD8+ T cells in healthy and convalescent COVID-19 individuals Cecily Choy, Jian Lu, Jiangyuan Li, Christopher Dunn, Tonya Wallace, Cuong Nguyen, et al. (+4)
319 [GO] 2023―Feb―07 Immune profiling of COVID-19 infection in pediatric solid organ transplantation Udeme D Ekong, Saikat Paul, Scott Royal, Joeffrey Chahine, Nada Yazigi, Stuart Kaufman, et al. (+4)
320 [GO] 2023―Feb―07 Aberrant CD39 levels and regulation mark COVID-19 late stage Maria Serena Longhi, Na Wang, Ahmadreza Kalbasi, Marta Vuerich, Zachary J. Manickas-Hill, Jonathan Hecht, et al. (+2)
321 [GO] 2023―Feb―07 Type 2 Diabetes Increased the Risk of Hyposmia in COVID-19 Mild Pneumonia Patients by Suppressing Nasal Immunity Jun Zhang, Ye Tao, Zhaohui Xu, Yehai Liu
322 [GO] 2023―Feb―07 Development of a quantitative COVID-19 Multiplex Assay and its use for serological surveillance in a low SARS-CoV-2 incidence community Cassandra M Guarino, Elisabeth Larson, Susanna Babasyan, Alicia Rollins, Lok Joshi, Melissa Laverack, et al. (+4)
323 [GO] 2023―Feb―07 Titers, prevalence and duration of SARS-CoV-2 antibodies in two waves of a local COVID-19 outbreak Jodi F Hedges, Macy A. Thomspon, Deann T. Snyder, Amanda Robison, Matthew P. Taylor, Mark A Jutila
324 [GO] 2023―Feb―07 Disadvantaged students at minority serving institutions became disproportionally affected by the current COVID-19 pandemic. Sahira Renteria, Ryan Stempek, Sandra R Olk, Nadeem Fazal
325 [GO] 2023―Feb―07 Obesity effects serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients Bonnie Blomberg, Lisa Reidy, Maria Romero, Alain Diaz, Carolyn Cray, Kristin Kahl, Daniela Frasca
326 [GO] 2023―Feb―07 SARS-CoV-2 mediated monocytes dysregulation may contribute to increase risk of cardiovascular risk in severe COVID-19 patients. Manuja Gayashan Bandara Gunasena, Yasasvi Wijewantha, Emily Bowman, Janelle Gabriel, Amrendra Kumar, Aaren Kettelhut, et al. (+9)
327 [GO] 2023―Feb―07 Diminished monocyte response in severe COVID-19 patients. Meredith E Davis-Gardner, Venkata Edara, Lilin Lai, Fengzhi Jin, Katharine Floyd, Lindsay Nyhoff, et al. (+12)
328 [GO] 2023―Feb―07 Abnormal C5 production and activation contributes to the mortality of COVID-19 patients Zhou Fang, Xiang Li, Tzu Hsuan Cheng, Shreya Desikan, Samrat Worah, Robert Foronjy, et al. (+11)
329 [GO] 2023―Feb―07 SARS-CoV-2 plasma viral load polarizes the systemic myeloid cell compartment towards an immunosuppressive/regulatory phenotype in severe COVID-19 patients Amelia Chiara Trombetta, Guilherme Borlido de Carvalho Farias, Ana Godinho-Santos, André MC Gomes, Pedro Rosmaninho, Carolina M. Conceição, et al. (+6)
330 [GO] 2023―Feb―07 Unique immune signatures predict potential cardiometabolic risk in severe COVID-19 patients and COVID-19 recovered individuals Namal Liyanage, Manuja Gunasena, Yasasvi Wijewantha, Emily Bowman, Janelle Gabriel, Amrendra Kumar, et al. (+9)
331 [GO] 2023―Feb―07 Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
332 [GO] 2023―Feb―07 Combinations of alum and synthetic toll-like receptor agonists as adjuvants for CoVID-19 vaccines Clara J Davison, Haley A Partlow, Stephanie K Lathrop, Karthik Siram, Walid Abdelwahab, David J Burkhart, Jay Evans
333 [GO] 2023―Feb―07 Host responses to feline coronavirus are significantly different in primary macrophages compared to CRFK cells. Yvonne Drechsler, Elton J.R. Vasconcelos, Lisa M Griggs, Pedro P.P.V. Diniz
334 [GO] 2023―Feb―07 Coronavirus induces diabetic macrophage-mediated inflammation via IFN-beta regulation of SETDB2 William James Melvin, Christopher Audu, Amrita Joshi, Frank Davis, Emily Barrett, Kevin Mangum, et al. (+3)
335 [GO] 2023―Feb―07 Characterization of cross-reactive immunity following coronavirus vaccination or natural infection Tanushree Dangi, Nicole M Palacio, Sarah Sanchez, Pablo Penaloza-MacMaster
336 [GO] 2023―Feb―07 Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses John Altin, Jason T Ladner, Denis Kainov, Sergey Shiryaev, Sierra Henson, Annalee Boyle, et al. (+2)
337 [GO] 2023―Feb―07 High levels of endemic coronaviruses reactive CD4+ T cells in SARS-CoV-2 seronegative health care workers Ricardo Filipe da Silva Antunes, Suresh Pallikkuth, Erin Williams, Esther Dawen Yu, Jose Mateus, Lorenzo Quiambao, et al. (+16)
338 [GO] 2023―Feb―07 Type I Interferon Shapes Humoral Immunity to SARS-CoV-2 Benjamin Goldman-Israelow, Tianyang Mao, Eric Song, Peiwen Lu, Patrick Wong, Carolina Lucas, et al. (+2)
339 [GO] 2023―Feb―07 IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10 Mary K Young, Christine Kornmeier, Rebecca Carpenter, Nick Natale, Jennifer Sasson, Michael Solga, et al. (+4)
340 [GO] 2023―Feb―07 Determining Adenosine Deaminase 1 (ADA-1) Impact on Immune Memory and Durability as a Molecular Adjuvant in a SARS-CoV-2 DNA Vaccine Formulation. Gina Cusimano, Ebony N. Gary, Matt Bell, Jennifer R Connors, Nicholas J. Tursi, Shiyu Zhang, et al. (+10)
341 [GO] 2023―Feb―07 Novel Mechanisms of Innate Immune System Regulation Following SARS-CoV-2 Exposure Irving C Allen, Hannah Ivester, Holly Morrison, Carla Finkielstein, Jonathan Auguste, Nisha Duggal, et al. (+4)
342 [GO] 2023―Feb―07 Development and Characterization of Potential Neutralizaing Antibodies to SARS-CoV-2 from Phage Display Human Antibody Library System In Ho Park, Sang Pil Lee, Sunha Yoon, Ji-Young Shin, Jooyeon Oh, Hoojung Lee, et al. (+3)
343 [GO] 2023―Feb―07 Natural infection with SARS-CoV-2 generates durable Spike S1 Receptor-Binding-Domain-specific memory B cell and neutralizing antibody responses. Pankaj Kumar Mishra, Natalie Bruiners, Rahul Ukey, Pratik Datta, Alberta Onyuka, Deborah Handler, et al. (+5)
344 [GO] 2023―Feb―07 BCG-derived peptides induce T cell cross-reactivity to Sars-CoV-2 homologues P J Eggenhuizen, Boaz H Ng, Janet Chang, Ashleigh L Fell, Joshua D Ooi
345 [GO] 2023―Feb―07 Frozen CyTOF panel enables robust and consistent longitudinal assessment of the SARS-CoV-2 immune landscape Carolina Acosta-Vega, David Skibinski, Anna Kus, Cate Speak, Alice Long, Uma Malhotra, et al. (+2)
346 [GO] 2023―Feb―07 An interferon-stimulated transcriptionally independent isoform of ACE2 inhibits SARS-CoV-2 infection Olusegun O Onabajo, Megan Stanifer, A. Rouf Banday, Joselin Vargas, Wusheng Yan, Adeola Obajemu, et al. (+5)
347 [GO] 2023―Feb―07 SARS-CoV-2 infection drives endothelial dysfunction indirectly through hypoxia and increased pro-inflammatory cytokine production Taejoon Won, Megan K Wood, David M Hughes, Monica V Talor, Roger A Johns, Nisha A Gilotra, et al. (+3)
348 [GO] 2023―Feb―07 SARs-CoV-2 Infection Impacts the Function and Phenotype of Plasmacytoid Dendritic Cells Alicia L Codrington, Hannah Dewald, David Elson, Abby Chopoorian, Krzysztof Zembrziglel, Claire Park, et al. (+3)
349 [GO] 2023―Feb―07 Endogenous Type I interferon signaling plays a pivotal role in restricted SARS-CoV-2 infection in human ACE2 transgenic mice Kempaiah Rayavara Kempaiah, Aleksandra Drelich, Jason C Hsu, Vivian Tat, Chien-Te K Tseng
350 [GO] 2023―Feb―07 In Silico Assessment of SARS-CoV-2 Mutations with Relevancy to Prophylactic and Monoclonal-Based Treatment Strategies Lora Benoit, Deena Mikbel, Mario Vilela, Yusur Alsalihi, Dina Shakran, Edward Merino, Ali Mohseni
351 [GO] 2023―Feb―07 The SARS-CoV-2 proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms Christine Vazquez, Sydnie Swanson, Seble Negatu, Mark Dittmar, Holly Ramage, Sara Cherry, Kellie Jurado
352 [GO] 2023―Feb―07 SARS-CoV-2 related cytokines induce barrier function changes in human aortic endothelial cell monolayers: Implications for cytokine storm and vascular dysfunction. Carmen Elaine Campbell, William Boisvert
353 [GO] 2023―Feb―07 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein Naveen Chandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, et al. (+11)
354 [GO] 2023―Feb―07 The comparison of two SARS-CoV-2 spike protein antigens in TLR-adjuvanted subunit vaccines. Haley A Partlow, Clara J. Davison, Stephanie K Lathrop, Jay T. Evans
355 [GO] 2023―Feb―07 HLA class II binding analysis for SARS-CoV-2 Spike through cell-surface MHC density assay Hiroko Miyadera, Nian Jiang
356 [GO] 2023―Feb―07 Co-immunization with adenosine deaminase rescues age-associated impairment of SARS-COV-2 synDNA vaccine-induced responses Ebony Nicole Gary, Jennifer Connors, Nicholas J. Tursi, Bryce Warner, Matthew Bell, Gina Cuismano, et al. (+9)
357 [GO] 2023―Feb―07 Pre-existing cellular immunity to SARS-CoV-2 through an immunodominant epitope Emma J Grant, Katie E Lineburg, Srividhya Swaminathan, Demetra S.M. Chatzileontiadou, Christopher Szeto, Hannah Sloane, et al. (+20)
358 [GO] 2023―Feb―07 Novel Multiplexed Assays for Antibody Isotypes against SARS-CoV-2 Using Flow Cytometry Kimvan T Tran, Julie Clor, Kamala Tyagarajan
359 [GO] 2023―Feb―07 Effect of SARS-CoV-2 vaccine on the breastmilk antibody response among lactating healthcare workers Lauren Stewart Stafford, Vivian Valcarce Luaces, Joseph Neu, Nicole Cacho, Leslie Parker, David Burchfield, et al. (+2)
360 [GO] 2023―Feb―07 SARS-CoV-2 vaccines induce potent immune responses in infant rhesus macaques Alan D Curtis, Carolina Garrido, Maria Dennis, Hongmei Gao, David Montefiori, Koen KA Van Rompay, et al. (+8)
361 [GO] 2023―Feb―07 Systematic examination of antigen-specific recall T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile Jaclyn C Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T Abe, et al. (+10)
362 [GO] 2023―Feb―07 Rapid activation and expansion of peripheral gammadelta (γδ) T cells in SARS-CoV-2-infected nonhuman primates following aerosol exposure Alyssa Fears, Edith Walker, Nicole Chirichella, Nadia Slisarenko, Brandon Beddingfield, Nicholas J Maness, et al. (+2)
363 [GO] 2023―Feb―07 In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response Matthew Schaller, Yamini Sharma, Zadia Dupee, Duy Nguyen, Juan Uruena, Ryan Smolchek, et al. (+3)
364 [GO] 2023―Feb―07 Differential use of complementarity-determining regions by synthetic nanobodies identifies multiple epitopes on receptor binding domain of SARS-CoV2 Javeed Ahmad Dhobi, Jiansheng Jiang, Lisa F Boyd, Kannan Natarajan, David H Margulies
365 [GO] 2023―Feb―07 Using standardized dry antibody panels for flow cytometry in the assessment of altered immune profiles in response to SARS-CoV2 infection Vashti Lacaille, Rita Bowers
366 [GO] 2023―Feb―07 SARS-CoV2 spike protein induces inflammatory molecules through TLR2 in macrophages and monocytes Hasan Zaki, Shahanshah Khan
367 [GO] 2023―Feb―07 Complex immunogenomic control of serum thyroid hormone levels in fetuses and piglets challenged with Porcine Reproductive and Respiratory Syndrome Virus Angelica G Van Goor, Alex Pasternak, Muhammed Walugembe, Glenn Hamonic, Jack Dekkers, John C. S. Harding, Joan K Lunney
368 [GO] 2023―Feb―07 Using practice tests as a vaccine to desensitize test anxiety in vulnerable students during pandemic induced lock-down. Aundriana Burtley, Uzoma Emeakoroha, Minh-Thu Nguyen, Jazmyne Durrah Simmons, Prabjyot Jhatu, Sonia Salamanca, Nadeem Fazal
369 [GO] 2023―Feb―07 The pandemic matrix gene is associated with increased pro-inflammatory immune responses during influenza virus infection Emily Fate Griffin, Shelly Curran, Mark Tompkins
370 [GO] 2023―Feb―07 Pan-academic in Pandemic! Remote learning goes viral, mostly out of control. Nadeem Fazal, Gulgaz Alakbarova
371 [GO] 2023―Jan―30 An Innate Checkpoint Determines Immune Dysregulation and Immunopathology during Pulmonary Murine Coronavirus Infection Sarah Grabherr, Alexandra Waltenspühl, Lorina Büchler, Mechthild Lütge, Hung-Wei Cheng, Sonja Caviezel-Firner, et al. (+3)
372 [GO] 2023―Jan―03 Meta-genomic detection of Candida spp. in the nasopharynx and upper airway of patients with severe COVID-19 Sarah C Glover, Vincent N Miao, Anna H Owings, Andrew W Navia, Ying Ting, Joshua D Bromley, et al. (+19)
373 [GO] 2023―Jan―03 Innate immune mechanisms underlying sex differences in COVID-19 Anshu Agrawal, Sudhanshu Agrawal, Jon Salazar, James Nguyen, Farah Rahmatpanah
374 [GO] 2023―Jan―03 Robust and prototypical immune responses towards COVID-19 BNT162b2 vaccines in Indigenous people Wuji Zhang, Lukasz Kedzierski, Brendon Y Chua, Adam K Wheatley, Louise Rowntree, Lilith Allen, et al. (+12)
375 [GO] 2023―Jan―03 Characterization of SARS-CoV-2-specific CD8+ T cells in COVID-19 convalescent, vaccinated, and individuals with respect to age Cecily Choy, Jian Lu, Jiangyuan Li, Humza Hemani, Joseph Chen, Ana Lustig, et al. (+13)
376 [GO] 2023―Jan―03 Sodium Pyruvate Inhalation for COVID-19 Long Hauler Symptoms - An Effective and Inexpensive Treatment Riley A Nadler
377 [GO] 2023―Jan―03 Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients Stefania Campana, Claudia De Pasquale, Giacomo Sidoti Migliore, Gaetana Pezzino, Riccardo Cavaliere, Emmanuele Venanzi Rullo, et al. (+7)
378 [GO] 2023―Jan―03 Immune determinants of cardiometabolic risk in pre-existing type-2 diabetes (T2D) severe COVID-19 patients Manuja Gayashan Bandara Gunasena, Yasasvi Wijewantha, Emily Bowman, Amendra Kumar, Krishanthi Weragalaarachchi, Jerra Furay, et al. (+8)
379 [GO] 2023―Jan―03 Exploration of shared antibody motifs in Kawasaki Disease (KD) and COVID-19 related Multisystem Inflammatory Syndrome of Childhood (MIS-C) Zehra Rahman, Mark Hicar
380 [GO] 2023―Jan―03 Bead-based Multiplex Assay Panels for Quantifying COVID-19 Vaccine-induced Serological Response, Neutralizing Antibodies and Cytokines Amy Zhao, Jessica Zhao, Edvelyn Webster, Cassandra Wheat, Binggang Sun, Jessie Ni
381 [GO] 2023―Jan―03 Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka J M K Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, Laksiri Gomes, Suranga Fernando, Dinuka Guruge, et al. (+19)
382 [GO] 2023―Jan―03 Changes of small non-coding RNAs by severe acute respiratory syndrome coronavirus 2 infection Wenzhe Wu, Ke Zhang, Eunjin Choi, Darby Buck, Binbin Wang, Awadalkareem Adam, et al. (+5)
383 [GO] 2023―Jan―03 Profiling MHC-I and MHC-II canonical and out-of-frame epitopes from SARS-CoV-2 and seasonal human coronavirus infected human cells Padma Pandurang Nanaware, Aniuska Becerra-Artiles, John Cruz, J. Mauricio Calvo-Calle, Muneeruddin Khaja, Scott A Shaffer, Lawrence J Stern
384 [GO] 2023―Jan―03 Evaluation of the long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus IL12 plasmid DNA Shawn M Jensen, Michael Afentoulis, Keith Wegmann, David A Canton, Christopher G Twitty, Bernard A Fox
385 [GO] 2023―Jan―03 Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries Yi Luan, Qianying Yuan, Qijun Wang, Susan Compton, Dianqing Wu, Wenwen Tang
386 [GO] 2023―Jan―03 Pan-coronavirus neutralizing S2 human monoclonal antibodies and utility of direct respiratory administration as combination therapy with S1 antibodies against SARS-CoV-2 James Kobie, Jun-Gyu Park, Sanghita Sarkar, Madhubanti Basu, Andreas Loos, Jennifer Woo, et al. (+6)
387 [GO] 2023―Jan―03 Chemokine CXCL10’s role in the immune response to SARS-CoV-2 Hannah Ivester, Holly Morrison, Carla Finkielstein, Nisha Duggal, James Weger, Irving C Allen
388 [GO] 2023―Jan―03 Development of Quantitative Spike and Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assays (ELISAs) for Measurement of Antibodies against SARS-CoV-2 Wen-Chieh Liao, Marissa Adame, Jess Webb, Dean Nguyen, Jessie Ni
389 [GO] 2023―Jan―03 Development of a Cell-based ELISA assay to assess memory IgG produced in vitro by B cells specific for spike protein of SARS-CoV-2 GIUSEPPE SCAPIGLIATI, Gianpaolo Zarletti, Massimo Tiberi, Veronica De Molfetta, Elisa Toppi, Paola Bossé
390 [GO] 2023―Jan―03 Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2 Oscar Rosas Mejia, Erin S. Gloag, Jianying Li, Marisa Ruane-Foster, Tiffany A Claeys, Daniela Farkas, et al. (+3)
391 [GO] 2023―Jan―03 Identifying highly conserved and immunogenic SARS-CoV-2 CD8+ T Cell Epitopes for Vaccine Design Jacqueline Carmona, Eric A Wilson, Padhmavathy Yuvaraj, Peaches R Ulrich, Abhishek Singharoy, Karen S Anderson
392 [GO] 2023―Jan―03 T Cell Responses In Children With Asthma Against SARS-CoV-2 Correlates To Asthmatic Outcomes Enwono Eyoh, Amelie Murrell, Derek Werthmann, Ivy Trinh, Addison Stone, Sruti Chandra, et al. (+9)
393 [GO] 2023―Jan―03 Assessing mucosal antibody responses to SARS-CoV-2 in humans and mice. Baweleta Isho, Kento Abe, Michelle Zuo, Alainna J Jamal, Eric Cao, Gary Chao, et al. (+6)
394 [GO] 2023―Jan―03 Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals Katelin Katsis, Mark B Leick, Rebecca C Larson, Trisha R Berger, Eva L Elder, Marcela V Maus, Kathleen M.E Gallagher
395 [GO] 2023―Jan―03 Differential serological immune imprinting following SARS-CoV-2 infection, vaccination, and breakthrough infection William Voss, Yimin Huang, Jeffrey Marchioni, Allison Seeger, Chelsea Paresi, Jessica Kain, et al. (+6)
396 [GO] 2023―Jan―03 Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection Salma Sheikh-Mohamed, Gary Chao, Baweleta Isho, Michelle Zuo, Carmit Cohen, Yaniv Lustig, et al. (+34)
397 [GO] 2023―Jan―03 Development of SARS-CoV-2 specific neutralizing recombinant monoclonal antibodies Pavitra Desai, Thangaraj Karuppuchamy, Nazia Syed, Sarath Unnikrishnan, Raghul Mathivanan, Nancy Priya, et al. (+4)
398 [GO] 2023―Jan―03 SARS-CoV-2 Spike395-404 is identified as a murine CD8+ T cell epitope in the receptor-binding domain of the SARS-CoV-2 spike protein Jihyun Yang, Eunjin Kim, Haryoung Poo
399 [GO] 2023―Jan―03 Cationic liposomes containing a TLR4 agonist promote the efficient development of cellular immunity against SARS-CoV-2 Spike protein in a subunit vaccine. Stephanie K Lathrop, Hardik H Amin, Clara J Davison, Haley A Partlow, Elizabeth K Lorentz, David J Burkhart, Jay T Evans
400 [GO] 2023―Jan―03 Persistence of immune memory to SARS-CoV-2 vaccine in lymphoid tissue Julia Davis-Porada, Ksenia Rybkina, Maya M.L. Poon, Daniel P Caron, Isaac J Jensen, Masaru Kubota, et al. (+8)
401 [GO] 2023―Jan―03 Longitudinal measurement of human immune responses to SARS-CoV-2 vaccines through serum immunoglobulins Kara Heatherton, Charleve Carey, William Hawkins, Stephanie Lacey
402 [GO] 2023―Jan―03 Vaccination of non-human primates with self-amplifying mRNA vaccines reveal two distinct immunotypes across major SARS-CoV-2 variants. Brian Martin Sullivan, Kathryn Hastie
403 [GO] 2023―Jan―03 Application of M-cell targeting ligand Co4B enhances Ag-specific mucosal and systemic immunity and protection against MERS-CoV infection after intranasal immunization Yong-Suk Jang, Ye Lin Yang, Ju Kim, Byeol-Hee Cho
404 [GO] 2023―Jan―03 Pandemic-induced pan-academic educational response in a minority university. Nadeem Fazal, Hafeez Faridi
405 [GO] 2023―Jan―03 Potential Clinical Applicability of The PHENotype SIMulator for In Silico Viral Co-Infection Studies in COVID-19 Naomi I. Maria, Rosaria Valentina Rapicavoli, Salvatore Alaimo, Evelyne Bischof, Alfredo Pulvirenti, Bud Mishra, et al. (+2)
406 [GO] 2023―Jan―03 Human KIR+ CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19 Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael Sikora, Vincent van Unen, et al. (+29)
407 [GO] 2023―Jan―03 Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19 Jian Zheng, Lok-Yin Roy Wong, Kevin Wilhelmsen, Kun Li, Miguel E Ortiz, Nicholas J Schnicker, et al. (+17)
408 [GO] 2023―Jan―03 Intracellularly Delivered Nuclear Localization Sequence Attenuates The Severity Of COVID-19 By Inhibits Interaction Of Inflammatory Transcription Factors And Importins Dongho Kim, Gyunam Kim, Dasom Shin, Sanghyeon Yu, Misuk Baek, Jaewook Lee, et al. (+7)
409 [GO] 2023―Jan―03 Epigenetic immunophenotyping in monitoring of SARS-CoV2 vaccine response and COVID-19 disease course Janine Nadine Jung, Ulrich Hoffmueller, Bjoern Samans, Eva Raschke, Marta Rossello Chornet, Konstantin Schildknecht, et al. (+6)
410 [GO] 2023―Jan―03 Respiratory humoral and cellular immune responses following COVID-19 mRNA vaccination Jinyi Tang, Cong Zeng, Thomas M Cox, Chaofan Li, Young Min Son, In Su Cheon, et al. (+14)
411 [GO] 2023―Jan―03 COVID-19 patients are characterized by increased levels of immune cell membrane-bound and soluble CD48 Hadas Tamar Pahima, Ilan Zaffran, Amir Jarjoui, Efrat Orenbuch-Harroch, Pratibha Gaur, Ilaria Puxeddu, et al. (+4)
412 [GO] 2023―Jan―03 Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination Lauren Stewart Stafford, Vivian Valcarce, Josef Neu, Martina Mueller, Adetola Louis-Jacques, Valeria Vicuna, et al. (+10)
413 [GO] 2023―Jan―03 An inactivated SARS-CoV-2 vaccine causes enhanced type 2 inflammation in mice during coronavirus challenge. Jake Dillard, Sharon Taft-Benz, Audrey C. Knight, Elizabeth J. Anderson, Sanjay Sarkar, Jennifer F. Loome, et al. (+3)
414 [GO] 2023―Jan―03 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in a Bat Gastrointestinal Organoid Model Marziah Hashimi, Thomas Sebrell, Jodi Hedges, Deann Teresa Snyder, Katrina Lyon, Michelle D Cherne, et al. (+7)
415 [GO] 2023―Jan―03 Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant Setsuko Mise-Omata, Mari Ikeda, Masaru Takeshita, Yoshifumi Uwamino, Masatoshi Wakui, Tomoko Arai, et al. (+14)
416 [GO] 2023―Jan―03 SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin West, Carmen Mirabelli, et al. (+24)
417 [GO] 2023―Jan―03 The SARS-CoV-2 encoded ORF8 protein Stimulates Human Monocytes to Produce Pro-Inflammatory Cytokines Gordon J Ruan, Xiaosheng Wu, Michelle K. Manske, Kevin E. Nowakowski, Jithma P. Abeykoon, Xingyi Tang, et al. (+8)
418 [GO] 2023―Jan―03 Maternal and Neonatal Antibody And T Cell Responses To SARS-CoV-2 Following Maternal Infection And/Or Vaccination Ivy Trinh, Enwono Eyoh, Amelie Murrell, Srushti Desai, Cody Lauritsen, Saraswatie Rambaran, et al. (+13)
419 [GO] 2023―Jan―03 Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation Jennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, Kevin J Selva, Timon Damelang, Ebene R Haycroft, et al. (+40)
420 [GO] 2023―Jan―03 Circulating Monocytes Co-expressing Surface ACE2 and TMPRSS2 upon TLR4/7/8 Activation Are Susceptible to SARS-CoV-2 Infection Yi Yao, Kalpana Subedi, Jonathan Z. Sexton, Tingting Liu, Namir Khalasawi, Carla Pretto, et al. (+8)
421 [GO] 2023―Jan―03 The E3-ligase TRIM7 acts as an antiviral factor by ubiquitinating the SARS-CoV-2 membrane protein to limit apoptosis and virus replication Maria J Gonzalez Orozco, Adam Hage, Hongjie Xia, Matthew Huante, Sarah van Tol, Maria I Giraldo, et al. (+8)
422 [GO] 2023―Jan―03 Discovery of potently-neutralizing antibodies against SARS-CoV-2 using Barcode Enabled Antigen Mapping (BEAM) Michael JT Stubbington, Bruce Adams, Daniel Reyes, Ariel Royall, Maengseok Song, Sean Marrache, et al. (+8)
423 [GO] 2023―Jan―03 Comprehensive analysis of the durability and the quality of humoral and T cell responses in SARS-CoV-2 vaccinated and infected subjects. Kyra Woloszczuk, Jennifer R Connors, Gina Cusimano, Matthew Bell, Sara Furukawa, Nataliya Melnyk, et al. (+6)
424 [GO] 2023―Jan―03 Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination Jessica A. Breznik, Angela Huynh, Ali Zhang, Lucas Bilaver, Hina Bhakta, Hannah D. Stacey, et al. (+7)
425 [GO] 2023―Jan―03 Efficacy of pediatric SARS-CoV-2 vaccines against high-dose B.1.617.2 challenge one year after vaccination of infant rhesus macaques Emma C Milligan, Katherine Olstad, Patricio Cano, Jenny Munt, Lisa Lindesmith, Trevor Scobey, et al. (+13)
426 [GO] 2023―Jan―03 Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, Pratima Kumari, Luis E Munoz, Judy Oh, et al. (+15)
427 [GO] 2023―Jan―03 Phenotypical changes in peripheral NK cells and their impact on the clinical outcomes of patients with severe pandemic influenza A(H1N1) Jazmín Ariadna Ramírez-Noyola, Luis Alejandro Fernández-López, Lynette Miroslava Pacheco-Hernández, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Beatriz Garcia-Padrón, et al. (+3)
428 [GO] 2023―Jan―02 MicroRNA-155 enhances T-cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease Laura L. Dickey, Colleen Worne, Jessica Glover, Joshua Daugherty, Thomas Lane, Ryan M O’Connell
429 [GO] 2023―Jan―02 Phospholipase A2 group IID is indispensable for coronavirus-specific humoral immune memory in middle aged mice Jian Zheng, Stanley Perlman
430 [GO] 2023―Jan―02 CD40-targeted S1 subunit vaccine protects against MERS-CoV and S1-associated pulmonary immunopathology in transgenic human DPP4 mouse model Anwar M Hashem, Abdullah Algaissi, Anurodh Agrawal, Sawsan Al-amri, Abdulrahman Almasoud, Naif Alharbi, et al. (+3)
431 [GO] 2023―Jan―02 Analysis of SARS-CoV-2 pathogenicity in COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions Emiko Urano, Tomotaka Okamura, Yasuhiro Yasutomi
432 [GO] 2023―Jan―02 “The Great College Escape”-the most difficult choice offered to COVID-19 generation of global students. Nadeem Fazal, Nihat Cebiyev, Gulgaz Alakbarova, Ayshan Huseynbayli, Azer Garajayev, Arzu Safarova, et al. (+2)
433 [GO] 2023―Jan―02 Mapping the spatial biology of COVID-19 immunopathology in placenta tissues Ning Ma, Oliver Braubach, Patricia Zadorosnei Rebutini, Cleber Machado-Souza, Emanuele Therezinha Schueda Stonoga, Lucia de Noronha, et al. (+2)
434 [GO] 2023―Jan―02 ADAM-17 protease promotes inflammation and mortality while decreasing viral burden in a COVID-19 mouse model Jodi F Hedges, Deann T. Snyder, Amanda Robison, Heather Walk, Karlin Havlak, Kelly Shepardson, et al. (+4)
435 [GO] 2023―Jan―02 Polyfunctionality of T cell immunity in pre-immune and naïve individuals after COVID-19 mRNA vaccination Vanessa S Moraes, Ted M Ross
436 [GO] 2023―Jan―02 Effect of methotrexate on response to Covid-19 mRNA vaccines in patients with Autoimmune Inflammatory Rheumatic Diseases: a longitudinal study Violeta Rus, Vinh Nguyen, Mallory Shriver, Mary Degrezia, Eaman Alhassan, Marcella Passetti, et al. (+2)
437 [GO] 2023―Jan―02 Molecular mechanisms of dexamethasone-mediated modulation of inflammatory and interferon responses in severe COVID-19 patients. Ameet A Chimote, Abdulaziz Alshwimi, Martina Chirra, Vaibhavkumar S Gawali, Kristin M Hudock, Margaret V Powers-Fletcher, Laura Conforti
438 [GO] 2023―Jan―02 Persistence of SARS-CoV-2 in long COVID-19 patients Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernandez, Justina Nadia Lee, Craig Ryan Joseph, Sílvia Guerrero, et al. (+3)
439 [GO] 2023―Jan―02 Epigenetic regulation of inflammatory genes involving histone methylation is associated with hyperimmune response in COVID-19 patients Xiaoming Yang, Xiaoming C Yang, Xiaoming Yang, Xiaoming Yang, Julian Julian, Timothy Schnell, et al. (+4)
440 [GO] 2023―Jan―02 Nasopharyngeal inflammatory lymphocytes perturbation in COVID-19 severity prediction Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Jin Zhang, Ramya Ramankutty Nair, Jun Dai, et al. (+5)
441 [GO] 2023―Jan―02 Circulating extracellular vesicles from patients with severe COVID-19 upregulate Cathepsin B and activate STAT3 in normal human mesangial cells Sarah C Glover, Yogesh Scindia, Lauren P Liu, Neha Dhaliwal, Haley Williams, Yilianys Pride, et al. (+3)
442 [GO] 2023―Jan―02 Immunogenicity and efficacy of a multiple antigen-presenting system (MAPS™) COVID-19 vaccine in Non-human Primates Gilles Besin, brian Cieslewicz, Daniel Makrinos, Renuka Haridas, Heidi Burke, Taylor Stevenson, Richard Malley
443 [GO] 2023―Jan―02 Severe acute respiratory syndrome coronavirus 2 vaccination induces short-term polyclonal antibody response against seasonal endemic coronaviruses Bindu Adhikari, Eugene M. Oltz, Richard J. Gumina, Linda J. Saif, Anastasia N. Vlasova
444 [GO] 2023―Jan―02 Identification of conserved coronavirus epitopes targeted by antibodies after SARS-CoV-2 infection or vaccination Todd Bradley, Eric Geanes, Cas LeMaster, Elizabeth R Fraley, Santosh Khanal, Rebecca McLennan, et al. (+2)
445 [GO] 2023―Jan―02 Repurposed antibiotic and antiviral drugs inhibit the immune evasive endoribonuclease of SARS-CoV-2 and restrict coronavirus infection in vitro Troy Alexander von Beck, Luis Mena Hernandez, Hongyi Zhou, Jeffrey Skolnick, Joshy Jacob
446 [GO] 2023―Jan―02 Correction: Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries
447 [GO] 2023―Jan―02 Evaluation of cellular immune responses induced in mice by alphavirus replicon particle vaccines for SARS-CoV (B190) Elizabeth A Reap, Pamela K Norberg, Aubrey D Watson, Chad Cecil, Jordan Wagner, Kurt I Kamrud, Jonathan Smith
448 [GO] 2023―Jan―02 Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191) Elizabeth A Reap, Aubrey D Watson, Pamela K Norberg, Chad Cecil, Ronna E Dornsife, Kurt I Kamrud, Jonathan Smith
449 [GO] 2023―Jan―02 In vitro assessment of neutrophil response to proteins and antibodies of SARS-CoV-2 Nathalie Bonatti Franco Almeida, Kayla Marie Fantone, Demba Sarr, Rafaella Fortini Queiroz Grenfell, Balazs Rada
450 [GO] 2023―Jan―02 Clonal structure and epitope specificity of Ad5-nCoV vaccine-induced T cell response to SARS-CoV-2 Savely Sheetikov, Alexandra A Khmelevskaya, Ksenia V Zornikova, Ivan V. Zvyagin, Alina S. Shomuradova, Andrei Afanasiev, et al. (+2)
451 [GO] 2023―Jan―02 C-type lectin receptor MGL-1 in SARS-CoV-2 disease pathogenesis Matthew B Huante, Maria J Gonzalez Orozco, Kubra F. Naqvi, Yazmin Berenice Martinez-Martinez, Vineet Menachery, Janice J Endsley, et al. (+3)
452 [GO] 2023―Jan―02 SARS-CoV-2 epitope-specific CD8+ clonotypes persist 8 month post-infection despite reduced clonality. Ksenia V Zornikova, Alexandra Khmelevskaya, Savely Sheetikov, Olga V. Shcherbakova, Dmitry Kirukhin, Aleksei Titov, et al. (+2)
453 [GO] 2023―Jan―02 Prediction of immunodominant CD4+ SARS-CoV-2 epitopes with TCR repertoire sequencing data Mikhail Pogorelyy, Anastasia Minervina, Elisa Rosati, Philip Mudd, Ali Ellebedy, Paul G Thomas
454 [GO] 2023―Jan―02 Children with Multi-System Inflammatory Syndrome (MIS-C) develop functionally competent T cell memory against SARS-CoV-2 following recovery Ksenia Rybkina, Marissa C Bradley, Joseph N Bell, Wenzhao Meng, Michael P DiLorenzo, Brett R Anderson, et al. (+4)
455 [GO] 2023―Jan―02 Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice Jacob S Yount, Ashley Zani, Adam D. Kenney
456 [GO] 2023―Jan―02 SARS-CoV-2 induced oxidative stress promotes HMGB1 secretion to induce inflammation Yashoda Madaiah Hosakote, Kempaiah Rayavara, Levine B Corri, Susan McLellan, Scott C Weaver, Ashok Chopra, Chein-Te K Tseng
457 [GO] 2023―Jan―02 Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 Infection Stephen T Yeung, Thomas A Premeaux, Toshiro Niki, Satish K Pillai, Kamal M Khanna, Lishomwa C Ndhlovu
458 [GO] 2023―Jan―02 Endogenous interferon-lambda signaling restricts virus replication and disease severity in a murine model of SARS-CoV-2 infection Abigail Solstad, Adam D. Kenney, Ashley Zani, Jacob S. Yount, Emily A. Hemann
459 [GO] 2023―Jan―02 Differences between autoantibodies induced by SARS-CoV-2 infection and Pfizer-BioNTech SARS-CoV-2 vaccination Eric S Geanes, Todd Bradley
460 [GO] 2023―Jan―02 Spike BATTLE: Simultaneous evaluation of antigen-specific B and T lymphocytes following natural SARS-CoV-2 infection and subsequent mRNA vaccination Krista L Newell, Mitchell J Waldran, Stephen J Thomas, Timothy P Endy, Adam T Waickman
461 [GO] 2023―Jan―02 Epitope-specific T cell response to SARS-CoV-2 infection and vaccination Anastasia Minervina, Mikhail Pogorelyy, Allison M Kirk, Ching-Heng Chou, E Kaitlynn Allen, Jeremy Chase Crawford, et al. (+2)
462 [GO] 2023―Jan―02 Baseline NK cell frequencies are greater in individuals with asymptomatic SARS-CoV-2 infection compared to those that develop symptomatic illness Elizabeth Graydon, Alyssa Lindrose, Stephen Anderson, Allison Malloy, Stephen Lizewski, Rhonda Lizewski, et al. (+5)
463 [GO] 2023―Jan―02 SARS-CoV-2 infection reduces the frequencies of angiogenic CD4 and CD8 T cells (Tang) Maryam AbdusSamad, Tong Li, Joseph Timpone, Jai Kumar, Princy Kumar, Ryan C Hunt, Marta Catalfamo
464 [GO] 2023―Jan―02 Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes Murugesan Rajaram, Qian Wu, Naresh Kumar, Noushin Salijoughian, Ashley Zani, Ashley Patton, et al. (+3)
465 [GO] 2023―Jan―02 Sequence similarity between SARS-CoV-2 Nucleocapsid and CNS proteins provides mechanistic insight into viral neuropathogenesis following infection Camille Lake, Joseph Breen
466 [GO] 2023―Jan―02 QuickSwitch™: a validated platform for both screening MHC binding SARS-CoV-2 peptides and making SARS-CoV-2 specific MHC class I and II tetramers. Yuri O Poluektov, Marc Delcommenne, Pirouz M Daftarian, Marybeth George
467 [GO] 2023―Jan―02 Antibody-dependent enhancement of SARS-CoV-2 spike binding to human ACE2 receptor by virus neutralizing antibodies Nicholas J Magazine, Yongjun Guan, Lei Yu, Mariano Carossino, Tianyi Zhang, Michael C McGee, Weishan Huang
468 [GO] 2023―Jan―02 Exposure to SARS-CoV-2 spike protein induces antigen specific IgE and basophil activation Tianyi Zhang, Nicholas Magazine, Michael Conrad McGee, Weishan Huang
469 [GO] 2023―Jan―02 A Longitudinal Study of Humoral Immune Responses to SARS-CoV-2 Spike Proteins in Gamma-Interferon-inducible Lysosomal Thiol Reductase Deficient Mice Xiao He, Li Guo, Hu Dai, Peter E Jensen
470 [GO] 2023―Jan―02 Antibody ‘Hotspots’ induce antibody-dependent cell-mediated cytotoxicity against SARS-CoV-2 spike-expressing lung fibroblasts Kayla Holder, Keeley Hatfield, Danielle Ings, Katie Fifield, Debbie Harnum, Michael Grant
471 [GO] 2023―Jan―02 Peripheral co-immunization with CCL27 drives robust mucosal responses to SARS-CoV-2 synDNA antigens and provides heterologous protection against Delta variant challenge Ebony Nicole Gary, Nicholas J Tursi, Bryce Warner, Elizabeth Parzych, Ali Ali, Darwyn Kobasa, et al. (+3)
472 [GO] 2023―Jan―02 TLR2 senses spike protein of SARS-CoV-2 to trigger inflammation Hasan Zaki, Shahanshah Khan
473 [GO] 2023―Jan―02 B cell receptor repertoire dynamics and convergent evolution following SARS-CoV-2 vaccination Elizabeth Ross Fraley, Santosh Khanal, Cas LeMaster, Stephen Pierce, Tomi Pastinen, Todd Bradley
474 [GO] 2023―Jan―02 SARS-CoV-2 vaccination induces T cell memory responses able to cross-recognize ongoing SARS-CoV-2 variants including omicron. Alba Grifoni, Alison Tarke, Jennifer Dan, Camila Coelho, Zeli Zhang, Daniela Weiskopf, et al. (+3)
475 [GO] 2023―Jan―02 Comprehensive comparison of adaptive immune responses to inactivated SARS-CoV-2 vaccine between young and old Chanchan Xiao, Zhiyao Ren, Bei Zhang, Lipeng Mao, Pengcheng Wang, Xiaofeng Liang, et al. (+2)
476 [GO] 2023―Jan―02 Hybrid immunity and vaccine breakthrough lead to robust humoral response and antibodies that effectively neutralize SARS-CoV-2 variants Timothy A Bates, Savannah K McBride, Hans C Leier, Zoe L Lyski, William B Messer, Marcel E Curlin, Fikadu G. Tafesse
477 [GO] 2023―Jan―02 Immune responses to SARS-Cov-2 variants in adult and elderly mRNA vaccine recipients Mladen Jergovic, Jennifer Uhrlaub, Makiko Watanabe, Christopher P Coplen, Janko Nikolich-Zugich
478 [GO] 2023―Jan―02 Computational fingerprinting of immune-mediated pressure on SARS-CoV-2 viral evolution reveals preliminary evidence for immune-evasion Tomer Hertz, Liel Cohen-Lavi, Sinai Sachren, Eilay Koren, Anat Burkovitz
479 [GO] 2023―Jan―02 Development of a cell free virus free beads-based SARS-Cov-2 virus neutralization assay Xiaohong Hou, Emily Sims, Wenjing Pan, Brittany Brown, Miranda Steele, Stephanie Song, Jian Han
480 [GO] 2023―Jan―02 Role(s) of Pulmonary Macrophage and Dendritic Cells in SARS-CoV-Induced Host Inflammatory Responses: An in vitro Model. (43.39) Tomoki Yoshikawa, Nan Wang, Clarence J Peters, Chien-Te K Tseng
481 [GO] 2023―Jan―02 Human Defensin-5 (HD-5) and HD-6 mRNA Produced by Intestinal Crypt Paneth Cells are Decreased in Fecal Samples of Patients Positive for SARS-CoV2 Lisa K Ryan, Tanya O. Robinson, Erika H. Figgins, Uyen ‘Emily’ Do, Kenneth J. Wilson, Sarah C. Glover, Gill Diamond
482 [GO] 2023―Jan―02 Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines Lauren Taylor Hamilton, Yoshinobu Koguchi, Tanisha Christie, Takashi Shimada, Noriko Iwamoto, Bernie Fox, et al. (+2)
483 [GO] 2023―Jan―02 OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV2 spike protein and RNA vaccinations Rebekka A Duhen, Michael Beymer, Shawn Jensen, Srinivas Abbina, Suraj Abraham, Anitha Thomas, et al. (+3)
484 [GO] 2023―Jan―02 Developing MHV-1 infection as an animal model for Severe Acute Respiratory Syndrome (SARS) (43.30) Aaruni Khanolkar, Lecia Pewe, Delia Tifrea, Stanley Perlman, John T. Harty
485 [GO] 2023―Jan―02 Do immune genes influence which pigs will have persistent Porcine Reproductive and Respiratory Syndrome virus (PRRSV) infections? (45.5) Joan K. Lunney, Raymond Rowland, Eric Nelson, Ramon Molina, Joseph Hermann, Daniel Kuhar, et al. (+3)
486 [GO] 2023―Jan―02 Cell death in pandemic and seasonal influenza viruses (VIR2P.1027) Boris Hartmann, Randy Albrecht, Nada Marjanovic, Soanli Patil, Miguel Fribourg, Stuart Sealfon
487 [GO] 2023―Jan―02 The role of T cell leptin signaling in 2009 pandemic H1N1 influenza infection mortality in obese mice (VIR2P.1013) J. Milner, Matthew Meyers, Patricia Sheridan, Peter Mancuso, Melinda Beck
488 [GO] 2023―Jan―02 Improvement of the aging-related reduced efficacy of the H1N1 pandemic influenza vaccine by the complex of poly-γ-glutamic acid and alum Jaemoo Kim, Yang Jihyun, Poo Haryoung
489 [GO] 2023―Jan―02 Female minority students-plight of staying alive in education during an unending pandemic! Nadeem Fazal, Minh-Thu Nguyen, Jazmyne Durrah Simmons, Sandra Olk, Prabjyot Jhatu
490 [GO] 2023―Jan―02 Is it not over yet? - pandemic-induced ongoing burn out continues for students in Azerbaijan. Nadeem Fazal, Nihat Cebiyev, Gulgaz Alakbarova, Ayshan Huseynbayli, Azer Garajayev, Arzu Safarova Safarova
491 [GO] 2023―Jan―01 IFN-γ expression by regulatory T cells in the CNS of mice persistently infected with neurotropic coronavirus (137.27) Jingxian Zhao, Stanley Perlman
492 [GO] 2023―Jan―01 The Role of IL-10 in Mice Infected with Neurotropic Murine Coronavirus (43.14) Kathryn A Trandem, Stanley Perlman
493 [GO] 2023―Jan―01 Rat coronavirus infection of alveolar type I cells causes neutrophil recruitment followed by resolution of infection (45.28) Tanya A. Miura, Joel Funk, Kathryn V. Holmes, Robert J. Mason
494 [GO] 2023―Jan―01 Selection of CTL Escape Mutants in Mice Infected with a Neurotropic Coronavirus: Quantitative Estimate of TCR Diversity in the Infected Central Nervous System Lecia Pewe, Stephen B. Heard, Conni Bergmann, Morris O. Dailey, Stanley Perlman
495 [GO] 2023―Jan―01 T-cell responses in mouse-adapted SARS-CoV infected mice (52.22) Jincun Zhao, Stanley Perlman
496 [GO] 2023―Jan―01 Protective and Pathologic roles of the Immune Response to Mouse Hepatitis Virus-1 (MHV-1): Implications for Severe Acute Respiratory Syndrome (128.8) Aaruni Khanolkar, Stacey M Hartwig, Lecia L Pewe, Steven M Varga, John T Harty
497 [GO] 2023―Jan―01 The role of different virus-specific effector memory T-cell subsets in response to influenza A/H3N2 and pandemic A/H1N1 strains in older compared to young adults (92.2) Xin Zhou, Janet McElhaney
498 [GO] 2023―Jan―01 Fatal outcome of pandemic H1N1 2009 influenza infection is associated with neutrophil and macrophage lung infiltration but not enhanced viral burden in pregnant mice. (111.3) Glendie Marcelin, Jerry Aldridge, Adrianus Boon, Susu Duan, Jerold Rehg, Richard Webby
499 [GO] 2023―Jan―01 Regulation of proinflammatory cytokine Interleukin-6 (IL-6) induction by NF-kappaB signaling in pandemic H1N1 influenza A virus-infected human bronchial epithelial cells (45.29) Zheng Xing, Wei Gao, Bingqian Qu, Xue Li, Yu Jin, Ku Yang, Carol Cardona
500 [GO] 2023―Jan―01 Cytokine expression pattern differences between conserved versus non-conserved influenza pandemic H1N1-specific CD4 T cells (49.15) Jason Weaver, Nan Deng, Courtney Bishop, Tim Mosmann
501 [GO] 2023―Jan―01 Positioning of the HA Globular Head within the TLR5 Agonist, Flagellin, Modulates the Immunogenicity and Reactogenicity of a Novel-H1 Pandemic Influenza Vaccine (136.13) Scott Umlauf, John Gathuru, Rodney Bell, Fu Hou, Lucia Reiserova, Langzhou Song, et al. (+3)
502 [GO] 2023―Jan―01 Adjuvanting influenza vaccines for enhanced immunity to seasonal or pandemic influenza virus. (75.9) Jeffery Fairman, Tim Carroll, Feng Liu, Kathy Hancock, Jacqueline Katz, Xiuhua Lu, et al. (+2)
503 [GO] 2023―Jan―01 Development of a rapid diagnostic kit for antigen and antibody of Middle East respiratory syndrome coronavirus Eun-Young Lee, Hae Li Ko, Seo-Yeon Jung, Jae-Hwan Nam
504 [GO] 2023―Jan―01 Early CD4 T cell help fails to rescue CD8 T cell-mediated control of neurotropic coronavirus infection (154.8) Timothy Phares, Stephen Stohlman, Cornelia Bergmann
505 [GO] 2023―Jan―01 Spike nanoparticle and recombinant adenovirus 5 vaccines induce specific antibodies against the Middle East respiratory syndrome coronavirus (MERS-CoV) Hyo-Jung Park, Eun-Young Lee, SeoYeon Jung, Hae Li Ko, Sang-Myeong Lee, Jae-Hwan Nam
506 [GO] 2023―Jan―01 Host Transcriptome Studies in Response to Feline Coronavirus Reveal Differences in Macrophages vs CRFK Yvonne Drechsler, Elton JR Vasconcelos, Pedro PVP Diniz
507 [GO] 2023―Jan―01 Age-related dysregulation in the lipidome compromises the immune response to the severe acute respiratory coronavirus (VIR5P.1140) RAHUL VIJAY, Michael Gelb, Makoto Murakami, Stanley Perlman
508 [GO] 2023―Jan―01 Anti-spike IgG exacerbates lung injury by skewing monocyte-macrophage responses during SARS-CoV infection Li Liu, Haibo Wang, Qiang Wei, Hangying Tang, Kenji Nishiura, Hauyee Kwok, et al. (+4)
509 [GO] 2023―Jan―01 Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Rudragouda Channappanavar, Anthony Fehr, Rahul Vijay, Zhao Jincun, David K Meyerholz, Stanley Perlman
510 [GO] 2023―Jan―01 Intranasal immunization of porcine reproductive and respiratory syndrome virus entrapped biodegradable PLGA- nanoparticles elicits virus specific cross-protective immune responses in pigs (161.21) Varun Dwivedi, Cordelia Manickam, Basavaraj Binjawadagi, Ruthi Patterson, Katie Dodson, Renukaradhya Gourapura
511 [GO] 2023―Jan―01 Analysis of the expressed porcine antibody repertoire in porcine and reproductive and respiratory syndrome virus infected pigs (P6077) John Schwartz, Michael Murtaugh
512 [GO] 2023―Jan―01 Porcine messenger RNA and microRNA pathway analysis of Porcine Reproductive and Respiratory Syndrome Virus infection Laura C Miller, Damarius Fleming
513 [GO] 2023―Jan―01 Understanding fetal immune responses to congenital porcine reproductive and respiratory syndrome virus infection Laura C Venner, Linjun Hong, Andrea Ladinig, John C S Harding, Joan Lunney
514 [GO] 2023―Jan―01 Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibody production to major envelope protein peptides (49.22) Juan Li, Michael Murtaugh
515 [GO] 2023―Jan―01 Porcine reproductive and respiratory syndrome virus non-structural protein Nsp2TF down-regulates Swine Leukocyte Antigen class I (SLA class I) expression Qian Cao, Sakthivel Subramaniam, Dianjun Cao, Xiang-Jin Meng
516 [GO] 2023―Jan―01 Comparative analysis of signature genes in Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)-infected porcine monocyte-derived dendritic cells at differential activation statuses. Laura C Miller, Yongming Sang, Darrell O Bayles, Frank Blecha
517 [GO] 2023―Jan―01 The pig heavy and light chain immunoglobulin repertoires provide insights into the adaptive immune response against porcine reproductive and respiratory syndrome virus (PRRSV). (160.4) John Schwartz, Michael Murtaugh, Juan Abrahante
518 [GO] 2023―Jan―01 Infection with Porcine Reproductive and Respiratory Syndrome virus (PRRSv) impacts immune cell metabolism without evidence of cell-mediated immune response. Crystal L Loving, Zahra F Olson, Wes P Schweer, Nicholas K Gabler
519 [GO] 2023―Jan―01 Vaccine Induced Protection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection in swine (113.3) Khushboo Hemnani, Jessie Trujillo, Tanja Opriessnig, Robert Messel, Gregory Tobin, Peter Nara
520 [GO] 2023―Jan―01 Probing host immune response to porcine reproductive and respiratory syndrome virus (PRRSV) infection using 3′RNAseq and NanoString arrays Kristen Walker, Linjun Hong, James M. Reecy, Elyn Fritz-Waters, Qian Dong, Robert R. R. Rowland, et al. (+5)
521 [GO] 2023―Jan―01 Transcriptomic analysis reveals the potential of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to modulate immune system activation related to host-pathogen and damage associated signaling in infected porcine monocytes. Laura C Miller, Damarius Fleming, Xiangdong Li, Darrell Bayles, Frank Blecha, Yongming Sang
522 [GO] 2023―Jan―01 PLGA nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine coadministered intranasally with a potent adjuvant elicits cross-protective immunity in the pig respiratory system (VAC7P.981) Basavaraj Binjawadagi, Varun Dwivedi, Cordelia Manickam, Kang Ouyang, Jordi Torrelles, Renukaradhya Gourapura
523 [GO] 2023―Jan―01 Natural killer T cell adjuvanted inactivated swine influenza virus vaccine enhanced the viral load and suppressed the host immune response to pandemic 2009 H1N1 virus in pigs (P6093) Renukaradhya Gourapura, Cordelia Manickam, Varun Dwivedi, Kang Ouyang, Basavaraj Binjawadagi, Kara Henn, et al. (+3)
524 [GO] 2023―Jan―01 Longitudinal analyses of human sera reveal expansions of antibody titers specific to previously-encountered pandemic and seasonal influenza viruses (P6366) Matthew Miller, Thomas Gardner, Florian Krammer, Lauren Aguado, Domenico Tortorella, Christopher Basler, Peter Palese
525 [GO] 2023―Jan―01 The role of mannose binding lectin (MBL) in co-infection of pandemic H1N1 and Streptococcus pneumoniae (168.14) Man To Ling, Yan Han, Wen Wei Tu, Pak Leung Ho, Yu Lung Lau
526 [GO] 2023―Jan―01 Comparing NKT cell therapy to oseltamivir phosphate (Tamiflu®) for controlling pandemic H1N1 influenza Bianca Libanori Artiaga, Guan Yang, Julia Loeb, Jürgen Richt, Jeffrey Abbott, John Lednicky, John Driver
527 [GO] 2023―Jan―01 The Complex of Poly-γ-Glutamic Acid and Alum Induces Cross-Protective Immunity of Pandemic H1N1 Influenza Vaccine Quyen Thi Nguyen, Chaewon Kwak, Jaemoo Kim, Jihyun Yang, Haryoung Poo
528 [GO] 2023―Jan―01 An investigation for IL-6 responses in patients with pandemic influenza A (H1N1) infection (168.20) Emin Bagriacik, Nurhan Albayrak, Basak Altas, Mustafa Ertek
529 [GO] 2023―Jan―01 Protection by a broadly neutralizing monoclonal antibody to pandemic Influenza requires selective Fc receptor engagement (P4216) David DiLillo, Gene Tan, Peter Palese, Jeffrey Ravetch
530 [GO] 2023―Jan―01 Poly gamma glutamic acid-chitosan nanogel dramatically enhances the protective efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine in mice and ferrets (P4281) Haryoung Poo
531 [GO] 2023―Jan―01 Suppression of dendritic cell necroptosis by pandemic influenza virus Boris M. Hartmann, Randy A Albrecht, Nada Marjanovic, Stuart C Sealfon
532 [GO] 2023―Jan―01 Age-associated cross-reactive antibody-dependent cellular cytotoxicity to 2009 H1N1 influenza prior to the pandemic (P6160) Sinthujan Jegaskanda, Karen Laurie, Thakshila Amarasena, Wendy Winnall, Marit Kramski, Robert De Rose, et al. (+4)
533 [GO] 2023―Jan―01 Contribution of 2009 pandemic swine-origin influenza virus gene segments to virulence and immunity (67.23) John Stambas, Justin Evans, Deborah Middleton, Sue Lowther, Rachel Robinson, Jessica Haining, et al. (+6)
534 [GO] 2022―Dec―31 Intraepithelial leukocytes contain a unique subpopulation of NK-like cytotoxic cells active in the defense of gut epithelium to enteric murine coronavirus. P S Carman, P B Ernst, K L Rosenthal, D A Clark, A D Befus, J Bienenstock
535 [GO] 2022―Dec―31 In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. S A Stohlman, G K Matsushima, N Casteel, L P Weiner
536 [GO] 2022―Dec―31 Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J L VanCott, T A Brim, J K Lunney, L J Saif
537 [GO] 2022―Dec―31 Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J L VanCott, T A Brim, R A Simkins, L J Saif
538 [GO] 2022―Dec―31 Antiidiotypic vaccination against murine coronavirus infection. A Lamarre, J Lecomte, P J Talbot
539 [GO] 2022―Dec―31 Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. A Suzumura, E Lavi, S Bhat, D Murasko, S R Weiss, D H Silberberg
540 [GO] 2022―Dec―31 Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J J Hooks, C Percopo, Y Wang, B Detrick
541 [GO] 2022―Dec―31 Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. H Körner, A Schliephake, J Winter, F Zimprich, H Lassmann, J Sedgwick, et al. (+2)
542 [GO] 2022―Dec―30 Protection from lethal coronavirus infection by immunoglobulin fragments. A Lamarre, P J Talbot
543 [GO] 2022―Dec―30 Antigenic Relationships Among the Coronaviruses of Man and Between Human and Animal Coronaviruses Kenneth McIntosh, Albert Z. Kapikian, Kathleen A. Hardison, Janet W. Hartley, Robert M. Chanock
544 [GO] 2022―Oct―20 Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection Anurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, David Agapiou, Elvis Pandzic, Nicholas A. Brasher, et al. (+18)
545 [GO] 2022―Oct―20 Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction Xiaohua Peng, Jooyoung Kim, Gayatri Gupta, Karen Agaronyan, Madeleine C. Mankowski, Asawari Korde, et al. (+16)
546 [GO] 2022―Oct―20 Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation Lydia L. Shook, Lindsay T. Fourman, Andrea G. Edlow
547 [GO] 2022―Jul―14 Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity Malena M. Pérez, Vinícius E. Pimentel, Carlos A. Fuzo, Pedro V. da Silva-Neto, Diana M. Toro, Thais F. C. Fraga-Silva, et al. (+27)
548 [GO] 2022―Jul―13 Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, et al. (+3)
549 [GO] 2022―Jul―12 Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1 Gina M. Cusimano, Ebony N. Gary, Matthew R. Bell, Bryce M. Warner, Jennifer Connors, Nicholas J. Tursi, et al. (+13)
550 [GO] 2022―Apr―29 Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil Hyon-Xhi Tan, Kathleen M. Wragg, Hannah G. Kelly, Robyn Esterbauer, Benjamin J. Dixon, Jillian S. Y. Lau, et al. (+7)
551 [GO] 2022―Apr―04 Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients Xiaoming Yang, Alex C. Rutkovsky, Juhua Zhou, Yin Zhong, Julian Reese, Timothy Schnell, et al. (+4)
552 [GO] 2022―Apr―04 Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women Nardhy Gomez-Lopez, Roberto Romero, Li Tao, Meyer Gershater, Yaozhu Leng, Chengrui Zou, et al. (+13)
553 [GO] 2022―Apr―01 Virus-Specific Regulatory T Cells Persist as Memory in a Neurotropic Coronavirus Infection Alan Sariol, Jingxian Zhao, Juan E. Abrahante, Stanley Perlman
554 [GO] 2022―Mar―23 SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients Bo Zhai, Karen Clarke, David L. Bauer, Krissy K. Moehling Geffel, Saran Kupul, Lucas J. Schratz, et al. (+5)
555 [GO] 2022―Mar―14 Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, et al. (+7)
556 [GO] 2022―Feb―28 Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG Veronica P. Costantini, Kenny Nguyen, Zoe Lyski, Shannon Novosad, Ana C. Bardossy, Amanda K. Lyons, et al. (+9)
557 [GO] 2022―Feb―04 Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly Lil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, et al. (+12)
558 [GO] 2022―Jan―31 Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine Alexey A. Komissarov, Inna V. Dolzhikova, Grigory A. Efimov, Denis Y. Logunov, Olga Mityaeva, Ivan A. Molodtsov, et al. (+6)
559 [GO] 2022―Jan―17 The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population Michael K. Tu, Samantha H. Chiang, Richard A. Bender, David T. W. Wong, Charles M. Strom
560 [GO] 2022―Jan―07 SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy Chao Sui, Tongyang Xiao, Shengyuan Zhang, Hongxiang Zeng, Yi Zheng, Bingyu Liu, et al. (+3)
561 [GO] 2022―Jan―05 Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease Taru S. Dutt, Stephanie M. LaVergne, Tracy L. Webb, Bridget A. Baxter, Sophia Stromberg, Kim McFann, et al. (+8)
562 [GO] 2021―Dec―13 Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset Jaclyn C. Law, Melanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, et al. (+10)
563 [GO] 2021―Nov―24 ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling Beibei Wu, Arunachalam Ramaiah, Gustavo Garcia, Spyridon Hasiakos, Vaithilingaraja Arumugaswami, Sonal Srikanth
564 [GO] 2021―Oct―13 Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan
565 [GO] 2021―Oct―04 Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection Against Secondary Infection Lydia M. Roberts, Forrest Jessop, Tara D. Wehrly, Catharine M. Bosio
566 [GO] 2021―Oct―04 SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals Yanling Liu, Patrick Budylowski, Shilan Dong, Zhijie Li, Sofiya Goroshko, Leslie Y. T. Leung, et al. (+8)
567 [GO] 2021―Aug―27 Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19 Qianting Yang, Yanling Wen, Furong Qi, Xiang Gao, Weixin Chen, Gang Xu, et al. (+8)
568 [GO] 2021―Aug―20 SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis Inês Alves, Manuel Machado Vicente, Joana Gaifem, Ângela Fernandes, Ana Mendes Dias, Cláudia Sousa Rodrigues, et al. (+6)
569 [GO] 2021―Aug―13 Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, et al. (+8)
570 [GO] 2021―Aug―04 Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19 Daniel Reynolds, Cristina Vazquez Guillamet, Aaron Day, Nicholas Borcherding, Rodrigo Vazquez Guillamet, José Alberto Choreño-Parra, et al. (+6)
571 [GO] 2021―Jul―26 The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated Shima Shahbaz, Lai Xu, Wendy Sligl, Mohammed Osman, Najmeh Bozorgmehr, Siavash Mashhouri, et al. (+4)
572 [GO] 2021―Jul―23 SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain Rafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, Laura Pérez-Alós, Cecilie Bo Hansen, Laust Bruun Johnsen, et al. (+10)
573 [GO] 2021―Jun―30 Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity William E. Matchett, Vineet Joag, J. Michael Stolley, Frances K. Shepherd, Clare F. Quarnstrom, Clayton K. Mickelson, et al. (+14)
574 [GO] 2021―Jun―28 SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19 José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, Charbel Maroun-Eid, Verónica Terrón-Arcos, Karla Montalbán-Hernández, et al. (+14)
575 [GO] 2021―Jun―28 A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs Deli Huang, Jenny Tuyet Tran, Linghang Peng, Linlin Yang, Raymond T. Suhandynata, Melissa A. Hoffman, et al. (+13)
576 [GO] 2021―Jun―02 Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation Gautam Anand, Alexandra M. Perry, Celeste L. Cummings, Emma Raymond, Regina A. Clemens, Ashley L. Steed
577 [GO] 2021―May―28 Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19 Kenneth B. Hoehn, Palaniappan Ramanathan, Avraham Unterman, Tomokazu S. Sumida, Hiromitsu Asashima, David A. Hafler, et al. (+5)
578 [GO] 2021―May―28 Metabolic Defects of Peripheral T Cells in COVID-19 Patients Xiaoju Liu, Juanjuan Zhao, Haiyan Wang, Wan Wang, Xu Su, Xuejiao Liao, et al. (+3)
579 [GO] 2021―May―21 Influenza Virus and SARS-CoV-2 Vaccines Adam M. Sandor, Michael S. Sturdivant, Jenny P. Y. Ting
580 [GO] 2021―May―12 Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors Bernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Carolin Ludwig, Tatjana Schwarz, et al. (+9)
581 [GO] 2021―May―12 Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques Xiaojuan Liu, Yuzhong Li, Hongjian Xiao, Yanwei Bi, Yue Gong, Zhengrong R. Hu, et al. (+6)
582 [GO] 2021―May―10 Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein Jake C. Harbour, Zoe L. Lyski, John B. Schell, Archana Thomas, William B. Messer, Mark K. Slifka, Jeffrey C. Nolz
583 [GO] 2021―May―10 Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination Bennett J. Davenport, Thomas E. Morrison, Ross M. Kedl, Jared Klarquist
584 [GO] 2021―May―05 Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain Grace Mantus, Lindsay E. Nyhoff, Robert C. Kauffman, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd, et al. (+11)
585 [GO] 2021―May―03 Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, et al. (+7)
586 [GO] 2021―Apr―28 Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire Coulon, Nisha R. Dhanushkodi, Aziz A. Chentoufi, Delia F. Tifrea, et al. (+9)
587 [GO] 2021―Apr―12 Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, Bo Feng, Tianxing Ji, et al. (+12)
588 [GO] 2021―Mar―29 Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease Philip S. Crooke, John T. Tossberg, Krislyn P. Porter, Thomas M. Aune
589 [GO] 2021―Feb―12 The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression Wei Huang, Mei Li, Guangwei Luo, Xiaojie Wu, Bintao Su, Lan Zhao, et al. (+6)
590 [GO] 2021―Feb―08 T Cell Phenotyping in Individuals Hospitalized with COVID-19 Janine Rupp, Barbara Dreo, Katharina Gütl, Johannes Fessler, Adrian Moser, Bernd Haditsch, et al. (+5)
591 [GO] 2021―Feb―05 IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study Marco Franzetti, Andrea Forastieri, Noemi Borsa, Alessandro Pandolfo, Chiara Molteni, Luca Borghesi, et al. (+15)
592 [GO] 2021―Jan―13 Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses Vineet Joag, Sathi Wijeyesinghe, J. Michael Stolley, Clare F. Quarnstrom, Thamotharampillai Dileepan, Andrew G. Soerens, et al. (+20)
593 [GO] 2020―Dec―30 Coronavirus Receptors as Immune Modulators Charan Kumar V. Devarakonda, Emily Meredith, Mallika Ghosh, Linda H. Shapiro
594 [GO] 2020―Dec―09 Repurposed Tocilizumab in Patients with Severe COVID-19 Jianbo Tian, Ming Zhang, Meng Jin, Fengqin Zhang, Qian Chu, Xiaoyang Wang, et al. (+12)
595 [GO] 2020―Dec―09 A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients Henning Zelba, David Worbs, Johannes Harter, Natalia Pieper, Christina Kyzirakos-Feger, Simone Kayser, et al. (+4)
596 [GO] 2020―Dec―04 Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, et al. (+6)
597 [GO] 2020―Nov―18 SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, et al. (+9)
598 [GO] 2020―Nov―18 Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T. Abe, et al. (+10)
599 [GO] 2020―Nov―05 SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M. Casasnovas, Daniel Fernández-Soto, Gloria Esteso, et al. (+11)
600 [GO] 2020―Oct―30 Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19 Erik H. Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar-de Heer, Gerard van Mierlo, et al. (+21)
601 [GO] 2020―Sep―25 Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19 Merve Kalkan Yazıcı, Meliha Meric Koç, Nesibe Selma Çetin, Elif Karaaslan, Gulay Okay, Bulent Durdu, et al. (+2)
602 [GO] 2020―Sep―21 Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm Alexandre E. Nowill, Pedro O. de Campos-Lima
603 [GO] 2020―Sep―04 Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee, Deepta Bhattacharya
604 [GO] 2020―Sep―02 Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients Renata Varnaitė, Marina García, Hedvig Glans, Kimia T. Maleki, John Tyler Sandberg, Janne Tynell, et al. (+10)
605 [GO] 2020―Aug―21 Neonatal and Children’s Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy Shokrollah Elahi
606 [GO] 2020―Aug―03 Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε Lok-Yin Roy Wong, Zi-Wei Ye, Pak-Yin Lui, Xuyang Zheng, Shuofeng Yuan, Lin Zhu, et al. (+9)
607 [GO] 2020―Jul―22 COVID-19: Complement, Coagulation, and Collateral Damage Martin W. Lo, Claudia Kemper, Trent M. Woodruff
608 [GO] 2020―Jul―17 SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production Rafael Franco, Rafael Rivas-Santisteban, Joan Serrano-Marín, Ana I. Rodríguez-Pérez, José L. Labandeira-García, Gemma Navarro
609 [GO] 2020―Jul―10 A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections Marika Orlov, Pandora L. Wander, Eric D. Morrell, Carmen Mikacenic, Mark M. Wurfel
610 [GO] 2020―Jun―26 A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection Wafaa B. Alsoussi, Jackson S. Turner, James B. Case, Haiyan Zhao, Aaron J. Schmitz, Julian Q. Zhou, et al. (+16)
611 [GO] 2020―Jun―08 Early Insights into Immune Responses during COVID-19 Ashley L. St. John, Abhay P. S. Rathore
612 [GO] 2020―Jun―03 Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19 Judy Chen, William J. Kelley, Daniel R. Goldstein
613 [GO] 2020―Jun―03 Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19 Jeremy K. Y. Yap, Miyu Moriyama, Akiko Iwasaki
614 [GO] 2020―May―18 COVID-19 as an Acute Inflammatory Disease Rose H. Manjili, Melika Zarei, Mehran Habibi, Masoud H. Manjili
 [1] 

614 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.015 sec